General Information of Disease (ID: DIS7HLUB)

Disease Name Type-1 diabetes
Synonyms
type I diabetes mellitus; juvenile diabetes; insulin dependent diabetes; type 1 diabetes; T1D; immune mediated diabetes; IDDM; T1DM; insulin-dependent diabetes mellitus; diabetes mellitis type I; diabetes mellitis type 1; type I diabetes
Disease Class 5A10: Diabetes mellitus
Definition A chronic condition characterized by minimal or absent production of insulin by the pancreas.
Disease Hierarchy
DISIUHAP: Type-1/2 diabetes
DISLAIH9: Autoimmune disorder of gastrointestinal tract
DISTWCN9: Autoimmune disorder of endocrine system
DIS7HLUB: Type-1 diabetes
ICD Code
ICD-11
ICD-11: 5A10
Expand ICD-10
E08,E09,E10,E11,E12,E13,L40
Expand ICD-9
250,250.01,696
Disease Identifiers
MONDO ID
MONDO_0005147
MESH ID
D003922
UMLS CUI
C0011854
OMIM ID
222100
MedGen ID
41522
HPO ID
HP:0100651
Orphanet ID
243377
SNOMED CT ID
46635009

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 11 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Canagliflozin DMFRM1I Approved Small molecular drug [1]
Carbamazepine DMZOLBI Approved Small molecular drug [2]
Empagliflozin DMRF9YK Approved Small molecular drug [3]
Hu neutral insulin DMOSYCU Approved NA [4]
Insulin-glargine DMR4HIW Approved Small molecular drug [1]
Insulin-lispro DM4O90W Approved Small molecular drug [5]
Pentoxifylline DMU3DNC Approved Small molecular drug [6]
Secukinumab DMYXT2U Approved Monoclonal antibody [7]
Sotagliflozin DMMLXA9 Approved Small molecular drug [1]
Teplizumab DMZ3P6C Approved Antibody [8]
Trofinetide DMPZ97S Approved Small molecular drug [9]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)
This Disease is Treated as An Indication in 65 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Balaglitazone DMXBHR6 Phase 3 Small molecular drug [10]
Diamyd DMOUGX1 Phase 3 NA [11]
Donislecel DMP13LL Phase 3 Cell therapy [12]
FARGLITAZAR DMOKT7Y Phase 3 Small molecular drug [13]
Insulin glargine biosimilar DMMREO0 Phase 3 NA [14]
Itolizumab DMGWVLX Phase 3 Antibody [15]
Ixmyelocel-T DMW7UL0 Phase 3 NA [16]
LAI287 DMHLO5G Phase 3 NA [14]
LATIN T1D DMAJM12 Phase 3 NA [17]
LY900014 DM49EQB Phase 3 NA [14]
Oral-lyn DMGTMMC Phase 3 NA [18]
PC-DAC:Insulin DMJBHO0 Phase 3 NA [19]
Peptide p277 DMFFUBQ Phase 3 NA [20]
Ragaglitazar DMFSHEM Phase 3 Small molecular drug [21]
SAR342434 DMR0EWV Phase 3 NA [14]
Taspoglutide DMPYET9 Phase 3 NA [22]
TESAGLITAZAR DMGRBN5 Phase 3 Small molecular drug [23]
HDV-insulin DM9N0TR Phase 2/3 NA [14]
BIOD-123 DM2VDUE Phase 2 NA [24]
CLBS03 DMLGG09 Phase 2 NA [1]
Dance-501 DMQ7D07 Phase 2 NA [14]
DV-100 DMRDD1C Phase 2 NA [25]
Iscalimab DMW4CR8 Phase 2 Antibody [26]
LAI338 DMSORN2 Phase 2 NA [27]
Lisofylline DMVU9X1 Phase 2 Small molecular drug [28]
MER-3001 DMIVR9K Phase 2 NA [1]
NN9828 DMOK5Y6 Phase 2 NA [1]
OI338GT DMNEHY1 Phase 2 NA [14]
Otelixizumab DMFNDBC Phase 2 Monoclonal antibody [29]
REMD 477 DM13OVF Phase 2 Antibody [30]
RG7426 DMWBEN6 Phase 2 NA [31]
TT-223 DMCDMFP Phase 2 NA [32]
TTP399 DMBKQSZ Phase 2 Small interfering RNA [33]
U-Strip Diabetes DMOU86T Phase 2 NA [14]
Ultra-rapid insulin DMNXT8C Phase 2 NA [14]
YG1699 DM1NR1J Phase 2 Small molecule [34]
AG019 DMEN2L7 Phase 1/2 Gene therapy [35]
AVT001 DMTUK2E Phase 1/2 Cell therapy [36]
Encapsulated human islet allografts DMLAHKD Phase 1/2 NA [37]
Encapsulated islet cell transplantation therapy DMMBDO3 Phase 1/2 NA [38]
Encapsulated transplanted islets DM9SVKO Phase 1/2 NA [39]
hESC-derived pancreatic endoderm (VC-01) DM6RDE0 Phase 1/2 Human embryonic stem (hES) cell-derived therapeutics [40]
KP-100 DML29RF Phase 1/2 NA [41]
PEC-Direct DM1GM7N Phase 1/2 Cell therapy [42]
PEC-Encap DMTIRKH Phase 1/2 Cell therapy [43]
SAR-161271 DMPXOGD Phase 1/2 NA [44]
VC-01 DM3G9WD Phase 1/2 NA [1]
VX-880 DM7WTP4 Phase 1/2 Cell therapy [45]
BHT-3201 DMWVAV8 Phase 1 NA [46]
BTI-410 DM3SPY9 Phase 1 Peptide [47]
IBC-VS01 DMRE6UT Phase 1 NA [48]
IMT-002 DMDCM9A Phase 1 Small molecule [49]
Insulin B chain vaccine DMEQVTK Phase 1 NA [50]
Insulin oral sublingual DMMR7CH Phase 1 NA [51]
MK-1092 DMHS79I Phase 1 NA [52]
MK-2640 DMFYJXP Phase 1 NA [1]
NexVax2 DMUAL7N Phase 1 NA [53]
NN-1218 DMDGCHR Phase 1 NA [14]
NN-414 DMRJEXM Phase 1 Small molecular drug [54]
NN1406 DMQ7N0C Phase 1 NA [14]
PF-06342674 DMASKX9 Phase 1 NA [55]
SAR440067 DMRVM71 Phase 1 NA [14]
Unacylated ghrelin DMI5UEB Phase 1 NA [56]
VCTX210 DMAA6G1 Phase 1 Cell therapy [57]
ZP2929 DMRVDUM Phase 1 NA [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 65 Drug(s)
This Disease is Treated as An Indication in 8 Discontinued Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
GW-501516 DMPL2KM Discontinued in Phase 4 Small molecular drug [58]
BM-17.0744 DM7ZI8A Discontinued in Phase 2 Small molecular drug [59]
CJC-1131 DMQD2LS Discontinued in Phase 2 Small molecular drug [60]
NBI-6024 DMTRMBL Discontinued in Phase 2 NA [61]
YM-440 DM7OHR6 Discontinued in Phase 2 NA [62]
AR-H049020 DMHZN42 Discontinued in Phase 1 NA [63]
DIO-901 DMAK3V7 Terminated NA [64]
Oral insulin DMW68CE Terminated NA [65]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)
This Disease is Treated as An Indication in 1 Investigative Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
BetaRx DMFDHR9 Investigative NA [66]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 354 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ADAMTS1 TTS2TEI Limited Biomarker [67]
ADAMTS4 TTYG6BU Limited Biomarker [68]
ADORA1 TTK25J1 Limited Altered Expression [69]
ADORA2A TTM2AOE Limited Biomarker [70]
ADRB1 TTR6W5O Limited Biomarker [71]
AGER TTMO9HF Limited Biomarker [72]
AGTR2 TTQVOEI Limited Biomarker [73]
AIF1 TT12MEP Limited Biomarker [74]
ALOX12 TT12ABZ Limited Altered Expression [75]
AMY2A TTCGSZ4 Limited Biomarker [76]
AOC3 TT7HC21 Limited Biomarker [77]
APOA4 TTNC3WS Limited Genetic Variation [78]
APOC3 TTXOZQ1 Limited Biomarker [79]
AQP9 TTQEI32 Limited Altered Expression [80]
ARG2 TTV1AG6 Limited Altered Expression [81]
BAK1 TTFM7V0 Limited Biomarker [82]
BLK TTNDSC3 Limited Genetic Variation [83]
BTLA TTER58P Limited Genetic Variation [84]
CALCR TTLWS2O Limited Altered Expression [85]
CASP3 TTPF2QI Limited Biomarker [86]
CBL TT7QT13 Limited Biomarker [87]
CBR1 TTVG0SN Limited Genetic Variation [88]
CCL20 TT2XAZY Limited Therapeutic [89]
CD209 TTBXIM9 Limited Genetic Variation [90]
CD276 TT6CQUM Limited Biomarker [91]
CD4 TTN2JFW Limited Biomarker [92]
CD52 TTQT5S9 Limited Biomarker [93]
CD59 TTBGTEJ Limited Biomarker [94]
CDC25C TTESBNC Limited Biomarker [95]
CDK5R1 TTBYM6V Limited Altered Expression [96]
CETP TTFQAYR Limited Genetic Variation [97]
CHRM2 TTYEG6Q Limited Biomarker [98]
CIT TT3BKTU Limited Genetic Variation [99]
CRBN TTDKGTC Limited Biomarker [100]
CSK TTX6F0Q Limited Biomarker [101]
CTSG TTQAJF1 Limited Altered Expression [102]
CTSH TT3G406 Limited Altered Expression [103]
CTSV TTSD9T1 Limited Genetic Variation [104]
CUBN TT9YLCR Limited Genetic Variation [105]
DHPS TTBO2A9 Limited Biomarker [106]
DUSP1 TTG8HIM Limited Biomarker [107]
E2F1 TTASI04 Limited Biomarker [108]
ERBB3 TTSINU2 Limited Genetic Variation [109]
ERN1 TTKIAT3 Limited Biomarker [110]
FABP1 TTIV96N Limited Biomarker [111]
FCGRT TTKLPHO Limited Biomarker [112]
FFAR2 TT0FYAN Limited Biomarker [113]
FGF21 TTQ916P Limited Altered Expression [114]
FPR2 TTOJ1NF Limited Biomarker [115]
FPR3 TT16TM5 Limited Biomarker [115]
FYN TT2B9KF Limited Genetic Variation [116]
G6PC TTBQMJ8 Limited Altered Expression [117]
G6PC2 TT7EV4P Limited Biomarker [118]
GH1 TTT3YKH Limited Biomarker [119]
GLA TTIS03D Limited Altered Expression [120]
GPR183 TTME5YJ Limited Altered Expression [121]
HLA-DQB2 TTL7VOU Limited Genetic Variation [122]
HMGCS2 TTS0EZJ Limited Altered Expression [123]
HSPE1 TTWYMFE Limited Biomarker [124]
HTR1A TTSQIFT Limited Biomarker [125]
ICA1 TTMX06B Limited Altered Expression [126]
IFNGR2 TT13TL0 Limited Biomarker [127]
IFNW1 TTS2TGF Limited Genetic Variation [128]
IKZF3 TTCZVFZ Limited Biomarker [129]
IL13RA1 TTNEAMG Limited Genetic Variation [130]
IL19 TT87RWS Limited Biomarker [131]
IL1R1 TTWOTEA Limited Genetic Variation [132]
IL1RL1 TT4GZA4 Limited Biomarker [133]
IL21R TTZO9B0 Limited Biomarker [134]
IL25 TTVMO5W Limited Biomarker [135]
IRAK3 TTBPJOK Limited Biomarker [136]
ITGA4 TTJMF9P Limited Biomarker [133]
ITGAL TT48WR6 Limited Biomarker [137]
KIF5A TTCJPAH Limited Genetic Variation [138]
KIR2DL1 TT4UXPE Limited Genetic Variation [139]
KIR2DL3 TTEX3SI Limited Genetic Variation [140]
KLRG1 TT299E6 Limited Altered Expression [141]
LANCL1 TTZW8NS Limited Altered Expression [142]
MADCAM1 TTBD6I7 Limited Genetic Variation [143]
MAP3K1 TTW8TJI Limited Altered Expression [144]
MAP3K14 TT4LIAC Limited Genetic Variation [116]
MAPK7 TTU6FSC Limited Biomarker [145]
MAS1 TTOISYB Limited Biomarker [146]
MASP2 TTR01E9 Limited Biomarker [147]
MGAT1 TTYJRN5 Limited Genetic Variation [148]
MMP10 TTXLEG7 Limited Altered Expression [149]
MTTP TTUS1RD Limited Biomarker [110]
NDUFA13 TTRU1NG Limited Biomarker [150]
NMUR2 TT2L6C5 Limited Biomarker [151]
NOD1 TTYSRXM Limited Biomarker [152]
NPY2R TTJ6WK9 Limited Genetic Variation [153]
NR4A3 TTJQB49 Limited Biomarker [154]
NSD1 TTTSJ3H Limited Genetic Variation [155]
NUDT3 TT69I0C Limited Genetic Variation [156]
PDCD2 TTYOVWN Limited Biomarker [157]
PF4 TTSG7Q5 Limited Biomarker [115]
PLIN1 TTIV27N Limited Genetic Variation [158]
PNPLA3 TTEUAEH Limited Altered Expression [159]
PRDX4 TTPBL9I Limited Biomarker [160]
PREP TTNGKET Limited Genetic Variation [161]
PSMB5 TT68GPI Limited Genetic Variation [162]
RBP4 TT0C8BY Limited Altered Expression [163]
RGS2 TTKB7T3 Limited Biomarker [164]
RIPK2 TTCQ2E5 Limited Altered Expression [165]
RPSA TTLUW5B Limited Altered Expression [142]
RXRB TTKLV96 Limited Biomarker [166]
S100A12 TTQ4ESF Limited Biomarker [167]
SELP TTE5VG0 Limited Altered Expression [168]
SERPINA6 TTJL8VG Limited Biomarker [169]
SERPINC1 TT4QPUL Limited Biomarker [170]
SETD7 TTJ0FSU Limited Genetic Variation [171]
SH2B3 TT36N7Z Limited Genetic Variation [172]
SLC19A2 TT2A1DZ Limited Genetic Variation [173]
SLC22A2 TT0XOJN Limited Genetic Variation [174]
SLC2A12 TTZO36H Limited Altered Expression [175]
SLC2A9 TTIF3GB Limited Altered Expression [176]
SUV39H1 TTUWQTK Limited Biomarker [171]
TLR1 TTW14D0 Limited Genetic Variation [177]
TLR6 TTWRI8V Limited Genetic Variation [177]
TLR8 TT8CWFK Limited Altered Expression [178]
TNFRSF18 TTG6LA7 Limited Altered Expression [179]
TNFSF13B TTWMIDN Limited Altered Expression [180]
TOR1A TTF85KW Limited Genetic Variation [181]
TRBC1 TT1DHW2 Limited Altered Expression [182]
TREM2 TTQRMSJ Limited Biomarker [183]
TYK2 TTBYWP2 Limited Biomarker [184]
UBC TTBP3XA Limited Biomarker [185]
UCP3 TT12RJK Limited Genetic Variation [186]
UGT1A1 TT34ZAF Limited Biomarker [187]
UNC13B TT948FC Limited Genetic Variation [188]
YES1 TT0SQ8J Limited Biomarker [189]
ZAP70 TTUMHT8 Limited Genetic Variation [190]
ATP4A TTF1QVM Disputed Biomarker [191]
BCL2A1 TTGT9C7 Disputed Biomarker [192]
CA5A TT75WPO Disputed Biomarker [193]
CCL3 TT8I4WB Disputed Biomarker [194]
CHAT TTKYFSB Disputed Altered Expression [195]
ENPEP TT9PBIL Disputed Biomarker [196]
FAF1 TTSKL3G Disputed Biomarker [197]
FAT1 TTGUJYV Disputed Altered Expression [198]
GAST TT4LRVO Disputed Biomarker [199]
IGFBP5 TTDWEA8 Disputed Altered Expression [200]
IL32 TTD4G7L Disputed Biomarker [201]
INPP5D TTTP2Z1 Disputed Altered Expression [202]
IRAK1 TTXAJWN Disputed Biomarker [203]
MFGE8 TT1GLAJ Disputed Altered Expression [204]
NAMPT TTD1WIG Disputed Altered Expression [205]
PCSK1 TTED9LZ Disputed Biomarker [206]
PMEL TT8MK59 Disputed Biomarker [207]
PTPN1 TTELIN2 Disputed Altered Expression [208]
REG3A TTL4H8N Disputed Biomarker [209]
SIRT6 TTUXYWF Disputed Altered Expression [210]
TNFRSF4 TTL31H0 Disputed Biomarker [211]
TPX2 TT0PHL4 Disputed Biomarker [207]
ALDH3A2 TTB6UM0 moderate Biomarker [212]
APOE TTKS9CB moderate Genetic Variation [213]
BCAT1 TTES57P moderate Biomarker [214]
CA14 TTEYTKG moderate Genetic Variation [215]
CBLB TTHRAIJ moderate Biomarker [216]
CCR1 TTC24WT moderate Altered Expression [217]
CD1A TTBGTFN moderate Altered Expression [218]
CR1 TTEA8OW moderate Biomarker [219]
DAG1 TT4X7PG moderate Genetic Variation [220]
DDIT4 TTVEOY6 moderate Biomarker [221]
FCER2 TTCH6MU moderate Biomarker [222]
FGR TTPOGS1 moderate Biomarker [223]
GPR35 TT254XD moderate Genetic Variation [220]
KAT2B TTVK7SB moderate Biomarker [224]
KCNC4 TTODZF1 moderate Genetic Variation [225]
KIR2DS2 TTV3CFI moderate Genetic Variation [226]
LAIR1 TTSI7A8 moderate Genetic Variation [227]
LPL TTOF3WZ moderate Biomarker [228]
LRRK2 TTK0FEA moderate Genetic Variation [220]
NAAA TTMN4HY moderate Biomarker [229]
PAX5 TTA4REJ moderate Genetic Variation [213]
PDX1 TT8SGZK moderate Biomarker [230]
QPCT TTJ7YTV moderate Genetic Variation [231]
SLC37A4 TT1KPBZ moderate Altered Expression [232]
SLCO1B1 TTFGXEB moderate Genetic Variation [233]
SMAD3 TTHQZV7 moderate Genetic Variation [220]
TNFRSF17 TTZ3P4W moderate Biomarker [234]
TNFRSF1B TT63WSF moderate Biomarker [235]
TNFRSF25 TTDV6BQ moderate Genetic Variation [236]
ABCC8 TTP835K Strong Genetic Variation [237]
ADAMTS5 TTXSU2Y Strong Altered Expression [238]
AGPAT1 TTPL1TK Strong Genetic Variation [239]
AKR1B1 TTFBNVI Strong Genetic Variation [240]
ALOX15 TTN9T81 Strong Biomarker [241]
AMD1 TTBFROQ Strong Genetic Variation [242]
ANPEP TTPHMWB Strong Biomarker [243]
APCS TTB7VAT Strong Biomarker [244]
ATXN2 TTPQJ7P Strong Genetic Variation [172]
CCL11 TTCF05Y Strong Altered Expression [245]
CCR3 TTD3XFU Strong Genetic Variation [246]
CD163 TTTZ9DE Strong Biomarker [247]
CD19 TTW640A Strong Biomarker [248]
CD274 TT8ZLTI Strong Altered Expression [249]
CD38 TTPURFN Strong Altered Expression [250]
CD69 TTPQE9F Strong Biomarker [251]
CD80 TT89Z17 Strong Biomarker [252]
CD86 TT53XHB Strong Altered Expression [253]
CDK4 TT0PG8F Strong Genetic Variation [254]
CELA1 TT3NKIB Strong Altered Expression [255]
CFTR TTRLZHP Strong Genetic Variation [256]
CHRM3 TTQ13Z5 Strong Altered Expression [257]
CLN3 TTORF9W Strong Genetic Variation [258]
COL1A2 TTUABC1 Strong Genetic Variation [239]
CPE TTXPWO6 Strong Biomarker [206]
CRP TTWRN6M Strong Biomarker [259]
CTRC TT3RMNA Strong Genetic Variation [256]
CTSC TT4H0V2 Strong Genetic Variation [260]
CXCR3 TT1UCIJ Strong Biomarker [261]
CXCR5 TTIW59R Strong Biomarker [261]
CYP21A2 TTP4GLG Strong Genetic Variation [262]
DKK1 TTE3RAC Strong Biomarker [263]
DLK1 TTF4AVB Strong Genetic Variation [264]
DPYD TTZPS91 Strong Biomarker [265]
EHMT1 TTOFXD7 Strong Biomarker [266]
EHMT2 TTS6RZT Strong Genetic Variation [239]
EIF2AK3 TT79U1M Strong Biomarker [267]
FOXO1 TTLRVIA Strong Biomarker [268]
GAL TTXZAJ5 Strong Biomarker [269]
GATA3 TT45KOB Strong Genetic Variation [270]
GCGR TT9O6WS Strong Biomarker [271]
GCK TTDLNGZ Strong Genetic Variation [272]
GEM TTAZF9M Strong Genetic Variation [139]
GFAP TTI6FFX Strong Altered Expression [273]
GLP1R TTVIMDE Strong Biomarker [266]
GNAO1 TTAXD8Z Strong Genetic Variation [122]
GZMB TTKEPHX Strong Genetic Variation [274]
HDAC3 TT4YWTO Strong Biomarker [275]
HLA-G TTLKFB3 Strong Genetic Variation [276]
HNF1A TT01M3K Strong Biomarker [272]
HNF4A TT2F3CD Strong Biomarker [277]
HP TTLC8E1 Strong Genetic Variation [278]
HPSE TTR7GJO Strong Biomarker [279]
HSD11B2 TT9H85R Strong Biomarker [280]
HSP90AA1 TT78R5H Strong Biomarker [281]
IDO1 TTZJYKH Strong Biomarker [282]
IFNG TT93WF5 Strong Biomarker [283]
IGFBP1 TTCJTWF Strong Altered Expression [284]
IGFBP3 TTZHNQA Strong Biomarker [285]
IL12A TTRTK6Y Strong Altered Expression [286]
IL15RA TTGN89I Strong Biomarker [287]
IL17A TTG0MT6 Strong Biomarker [288]
IL18RAP TTZUJVE Strong Genetic Variation [289]
IL2 TTF89GD Strong Altered Expression [290]
IL23R TT6H4QR Strong Biomarker [291]
IL2RB TT9721Y Strong Biomarker [292]
IL7R TTAWI51 Strong Biomarker [293]
IL9 TT0JTFD Strong Biomarker [294]
INSR TTCBFJO Strong Biomarker [295]
KIR2DL2 TTU0P73 Strong Genetic Variation [296]
KIR2DS1 TTVWAGF Strong Genetic Variation [139]
KIR3DL2 TTQH3N0 Strong Genetic Variation [139]
LEP TTBJEZ5 Strong Altered Expression [297]
LPA TTU9LGY Strong Biomarker [298]
LTB4R TTN53ZF Strong Biomarker [299]
MAPK14 TTQBR95 Strong Genetic Variation [300]
MAPT TTS87KH Strong Genetic Variation [258]
MMP14 TTJ4QE7 Strong Biomarker [301]
NOS1 TTZUFI5 Strong Biomarker [302]
NOS3 TTCM4B3 Strong Biomarker [303]
NOTCH4 TTXDIK2 Strong Genetic Variation [239]
NPY TT64REZ Strong Biomarker [304]
PDCD1 TTNBFWK Strong Biomarker [305]
PML TTLH9NY Strong Biomarker [306]
PRKCQ TT1MS7X Strong Genetic Variation [131]
PRSS1 TT2WR1T Strong Biomarker [256]
PSMB8 TTEAD9J Strong Genetic Variation [307]
PSMB9 TTOUSTQ Strong Genetic Variation [239]
PTGFR TTT2ZAR Strong Genetic Variation [308]
RENBP TTZCG0Q Strong Biomarker [309]
SELE TT1PL7M Strong Altered Expression [310]
SELL TT2IYXF Strong Biomarker [311]
SERPINA1 TTA7UJC Strong Biomarker [312]
SIRT5 TTH0IOD Strong Genetic Variation [313]
SLC18A2 TTNZRI3 Strong Biomarker [314]
SLC44A4 TT0NYDG Strong Genetic Variation [239]
SLC5A1 TT2UE56 Strong Biomarker [315]
SLC5A2 TTF8JAT Strong Biomarker [316]
SNCA TT08OSU Strong Altered Expression [317]
SOCS1 TT8COJM Strong Genetic Variation [318]
STAT1 TTN7R6K Strong Genetic Variation [319]
STAT3 TTHJT3X Strong Genetic Variation [319]
TBX21 TTNF9PH Strong Biomarker [320]
TCF7L2 TT80QAL Strong Genetic Variation [321]
TNFAIP3 TT5W0IO Strong Genetic Variation [322]
TNFRSF11A TT3K9S2 Strong Biomarker [323]
TNFRSF11B TT2CJ75 Strong Biomarker [263]
TNFRSF9 TTPW9LJ Strong Biomarker [324]
TNFSF10 TTA5MS9 Strong Genetic Variation [325]
TNFSF11 TT9E8HR Strong Biomarker [263]
TNFSF15 TTEST6I Strong Genetic Variation [220]
TNFSF4 TTBW580 Strong Biomarker [211]
TPO TT52XDZ Strong Biomarker [326]
TRAF6 TTCDR6M Strong Biomarker [203]
TRB TT84HCW Strong Altered Expression [182]
TREM1 TTHZQP0 Strong Biomarker [327]
TRPC6 TTRBT3W Strong Genetic Variation [328]
TRPV1 TTMI6F5 Strong Biomarker [329]
TSPO TTPTXIN Strong Biomarker [330]
TXN TTZJ5U9 Strong Altered Expression [331]
UCP2 TTSC2YM Strong Genetic Variation [332]
VWF TT3SZBT Strong Biomarker [333]
ZFP36L1 TT8QVJO Strong Genetic Variation [334]
ACR TTAHE2N Definitive Biomarker [335]
ATIC TT9NVXQ Definitive Biomarker [336]
BMP6 TT07RIB Definitive Biomarker [337]
CCR2 TTFZYTO Definitive Biomarker [338]
CCR6 TTFDB30 Definitive Biomarker [261]
CCR8 TTE836A Definitive Biomarker [339]
CD14 TT6I7DC Definitive Biomarker [340]
CD27 TTDO1MV Definitive Genetic Variation [251]
CFP TTLA0VS Definitive Biomarker [198]
DMD TTWLFXU Definitive Biomarker [341]
EIF5A TTIVCNR Definitive Biomarker [342]
ENTPD1 TTYM8DJ Definitive Altered Expression [343]
FABP2 TTS4YLO Definitive Biomarker [344]
FGF14 TTKJX1V Definitive Biomarker [345]
GDF5 TT37XV9 Definitive Biomarker [346]
HSD11B1 TTN7BL9 Definitive Genetic Variation [347]
HSD17B4 TTL1WGS Definitive Genetic Variation [348]
HSPD1 TT9HL5R Definitive Biomarker [349]
HTRA1 TT8POQR Definitive Altered Expression [238]
ICOS TTE5VP6 Definitive Altered Expression [350]
ICOSLG TTB9Z8R Definitive Genetic Variation [351]
IL1RN TT6GSR3 Definitive Genetic Variation [352]
IL22 TTLDX4N Definitive Biomarker [353]
IL23A TTC1GLB Definitive Biomarker [354]
ITGAM TTB69FJ Definitive Biomarker [251]
ITGB7 TTLT9XQ Definitive Biomarker [355]
KCNJ3 TTGM19J Definitive Altered Expression [356]
LCN2 TTKTLAI Definitive Biomarker [357]
LHCGR TT2O4W9 Definitive Biomarker [358]
MC4R TTD0CIQ Definitive Altered Expression [359]
MS4A1 TTUE541 Definitive Biomarker [360]
MSTN TTM8I2X Definitive Biomarker [361]
NCF1 TTZ4JC3 Definitive Biomarker [362]
NCR1 TTQNRJM Definitive Biomarker [363]
NLRP1 TTQX29T Definitive Genetic Variation [364]
NLRX1 TTKT026 Definitive Biomarker [365]
PCSK9 TTNIZ2B Definitive Biomarker [366]
PFKFB3 TTTHMQJ Definitive Altered Expression [367]
PLA2G7 TTDNFMT Definitive Biomarker [368]
SDC2 TT5H2F0 Definitive Altered Expression [279]
SIGMAR1 TT5TPI6 Definitive Altered Expression [369]
SLC19A3 TT9BTWM Definitive Genetic Variation [370]
SOST TTYRO4F Definitive Biomarker [263]
TKT TT04R7I Definitive Biomarker [371]
TLR3 TTD24Y0 Definitive Biomarker [372]
TSPAN7 TTMT6VE Definitive Biomarker [373]
TXNIP TTTLDZK Definitive Altered Expression [374]
UCP1 TTI12YJ Definitive Biomarker [297]
------------------------------------------------------------------------------------
⏷ Show the Full List of 354 DTT(s)
This Disease Is Related to 17 DTP Molecule(s)
Gene Name DTP ID Evidence Level Mode of Inheritance REF
SLC22A4 DT2EG60 Limited Genetic Variation [375]
SLC22A5 DT3HUVD Limited Genetic Variation [375]
SLC26A3 DTN1FMD Limited Genetic Variation [376]
SLC2A6 DTS4MKQ Limited Altered Expression [176]
SLC2A8 DT2I7BM Limited Altered Expression [175]
SLC5A8 DTE3TAW Limited Biomarker [377]
SLC6A6 DTHWCVA Limited Biomarker [378]
SLC7A9 DTP7AEQ Limited Genetic Variation [379]
SLC9C1 DT9J8DO Limited Altered Expression [380]
ATP7A DT0LT17 Disputed Altered Expression [381]
SLC35A1 DTVZIRG Disputed Biomarker [382]
ABCC11 DTWN7FC moderate Altered Expression [383]
SLC25A20 DTQOUM4 moderate Genetic Variation [384]
SLC25A3 DTCRIWV Strong Biomarker [385]
SLC29A3 DTZAWTH Strong Genetic Variation [386]
SLC2A2 DTUJPOL Definitive Genetic Variation [387]
SLC2A3 DT9SQ3L Definitive Biomarker [388]
------------------------------------------------------------------------------------
⏷ Show the Full List of 17 DTP(s)
This Disease Is Related to 20 DME Molecule(s)
Gene Name DME ID Evidence Level Mode of Inheritance REF
AOC2 DE8DP90 Limited Biomarker [77]
BAAT DERA3OF Limited Biomarker [389]
CHST3 DEQIZP2 Limited Biomarker [390]
CYP7A1 DEDZRQ1 Limited Altered Expression [391]
DDAH1 DEY0TQC Limited Genetic Variation [392]
DHCR7 DEL7GFA Limited Genetic Variation [393]
GGCT DEKW6PB Limited Genetic Variation [394]
HK1 DEDMAGE Limited Altered Expression [395]
CHDH DEAHED0 Disputed Genetic Variation [396]
LDHC DEQG7F9 Disputed Genetic Variation [397]
ADH5 DEIOH6A moderate Altered Expression [212]
ABO DESIA7R Strong Genetic Variation [398]
CYP2R1 DEBIHM3 Strong Genetic Variation [399]
GCLC DESYL1F Strong Genetic Variation [400]
GSTT1 DE3PKUG Strong Genetic Variation [401]
PGM1 DEA3VM1 Strong Genetic Variation [131]
CEPT1 DEL87ZT Definitive Biomarker [402]
CYP27A1 DEBS639 Definitive Altered Expression [403]
PER1 DE9HF0I Definitive Genetic Variation [404]
WARS1 DEPVE0M Definitive Biomarker [267]
------------------------------------------------------------------------------------
⏷ Show the Full List of 20 DME(s)
This Disease Is Related to 471 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
ACSL1 OTB06ESI Limited Biomarker [405]
ADA2 OTGCV24S Limited Genetic Variation [406]
ADAD1 OTXRDF3Z Limited Genetic Variation [407]
ADAMTS3 OT2U6VF5 Limited Biomarker [68]
ADCY10 OTYSTB0R Limited Genetic Variation [408]
ADD2 OTRCPCD2 Limited Genetic Variation [409]
ADIPOR1 OT65ZFZN Limited Biomarker [410]
ADIPOR2 OT2HDTL8 Limited Altered Expression [411]
AIFM1 OTKPWB7Q Limited Biomarker [412]
ALMS1 OTW66JKS Limited Genetic Variation [413]
ALOX15B OTWQQ08W Limited Biomarker [414]
ALYREF OTOF2ADD Limited Genetic Variation [415]
ANXA13 OTM33P73 Limited Biomarker [416]
APBB1IP OTN02KUV Limited Biomarker [417]
APOA5 OTEVKLVA Limited Genetic Variation [418]
APPL1 OT8VR95S Limited Altered Expression [419]
ARHGEF2 OTBQTFRT Limited Altered Expression [142]
ARID2 OTIRJXWM Limited Altered Expression [420]
ARMH1 OTTJC0D6 Limited Altered Expression [142]
ASPN OTYJM80N Limited Biomarker [421]
ATP2C1 OTQN51T3 Limited Biomarker [422]
ATP6V1E1 OT76J5R9 Limited Biomarker [423]
BACH2 OT17GS18 Limited Genetic Variation [424]
BANK1 OTXAAA11 Limited Genetic Variation [425]
BATF OT9VSD2D Limited Biomarker [129]
BTC OTW4B2O0 Limited Biomarker [426]
BTN3A2 OT3DIBU3 Limited Biomarker [427]
C1QTNF8 OTU5Z3YK Limited Biomarker [428]
C1QTNF9 OTLI3VA3 Limited Altered Expression [429]
CARD8 OTXXZYWU Limited Biomarker [430]
CCL3L1 OTQXCYB1 Limited Biomarker [431]
CD1D OT3ROU4J Limited Altered Expression [432]
CD226 OT4UG0KB Limited Genetic Variation [258]
CD247 OT45FGUX Limited Genetic Variation [190]
CD2AP OTC76KQM Limited Biomarker [433]
CDCA5 OTZLCQ5U Limited Altered Expression [96]
CDCA7 OT12HDZY Limited Genetic Variation [434]
CEACAM21 OTHVCMIP Limited Biomarker [435]
CEP135 OT1O9XYJ Limited Genetic Variation [153]
CFAP97 OT0RSQO4 Limited Altered Expression [163]
CLIP1 OTTGAEJE Limited Biomarker [436]
CLIP2 OTSCIQIY Limited Biomarker [436]
COBL OTTB4VFQ Limited Biomarker [289]
CRYGD OTW29JC4 Limited Biomarker [437]
CSGALNACT1 OTBML9D9 Limited Biomarker [438]
CTRL OTB6NA5O Limited Biomarker [439]
CYTB OTAHB98A Limited Biomarker [440]
DAXX OTX6O7PL Limited Biomarker [166]
DDAH2 OT8Q40G2 Limited Genetic Variation [392]
DDIT3 OTI8YKKE Limited Biomarker [412]
DDX39A OT0Z6E1K Limited Genetic Variation [379]
DESI1 OTFNIW98 Limited Biomarker [441]
DGCR2 OTEGL17Z Limited Biomarker [442]
DKK4 OTWCCVF6 Limited Biomarker [443]
DNTT OTFSEF12 Limited Genetic Variation [444]
DOCK11 OTFSTN6A Limited Genetic Variation [445]
DPYS OTLTUIVL Limited Biomarker [265]
EBNA1BP2 OTBRVMZH Limited Altered Expression [142]
EFHB OT83HFEP Limited Biomarker [435]
EFNA1 OTU2NUA2 Limited Biomarker [151]
ELF3 OTUTLEQO Limited Altered Expression [165]
ELMO1 OTY2ORXK Limited Genetic Variation [446]
ERRFI1 OT7VZ2IZ Limited Biomarker [447]
F8A1 OTXTQ59R Limited Genetic Variation [448]
FAM167A OT9JF3JQ Limited Genetic Variation [83]
FCN2 OTTHJBKZ Limited Altered Expression [96]
FHOD3 OT1WUBQX Limited Genetic Variation [449]
FLVCR1 OT9XCFOC Limited Biomarker [450]
FOXF1 OT2CJZ5K Limited Altered Expression [451]
FYB1 OT6345CH Limited Genetic Variation [452]
GBA3 OT86XWU2 Limited Biomarker [169]
GCHFR OTEOT8GI Limited Altered Expression [96]
GCKR OTSIWXGG Limited Genetic Variation [453]
GFER OTVK43OK Limited Biomarker [454]
GIMAP4 OTEUZH06 Limited Genetic Variation [455]
GLIS3 OTBC960E Limited Genetic Variation [456]
GNB3 OTA6HYBA Limited Genetic Variation [457]
GPT2 OTS5VF7N Limited Genetic Variation [458]
GSDMA OT912R2E Limited Biomarker [459]
HARS1 OTHOEOTS Limited Biomarker [352]
HCCS OTQE88BE Limited Biomarker [460]
HGS OTCYYCAC Limited Biomarker [352]
HLA-DQA2 OT1DH0N9 Limited Genetic Variation [461]
HNRNPF OTSMBXMF Limited Altered Expression [462]
HNRNPK OTNPRM8U Limited Altered Expression [462]
HSPA2 OTSDET7B Limited Genetic Variation [463]
IFNA17 OTHXRYG3 Limited Biomarker [128]
IGF2BP2 OT4ZSEEE Limited Genetic Variation [464]
IL17C OTKXIVNQ Limited Altered Expression [465]
IL17RB OT0KDNSF Limited Biomarker [135]
IL18R1 OT83XMPQ Limited Biomarker [133]
INPPL1 OTCDAVBQ Limited Genetic Variation [466]
IVL OT4VPNGY Limited Altered Expression [429]
KCNE1 OTZNQUW9 Limited Genetic Variation [88]
KIR2DL5A OT09FZE1 Limited Biomarker [467]
KIR2DL5B OTSV0JL9 Limited Biomarker [467]
KIR2DS4 OT00N6UJ Limited Biomarker [468]
KLRC3 OT9EPHV3 Limited Biomarker [469]
KLRD1 OTMYLOV4 Limited Altered Expression [469]
KLRF1 OTGHZ7FU Limited Biomarker [115]
LARS1 OT4557NF Limited Biomarker [352]
LBR OT1HG3HG Limited Biomarker [470]
LRBA OTOUZN9G Limited Genetic Variation [471]
MAFA OTBCA105 Limited Genetic Variation [472]
MCF2L2 OTOGFMIH Limited Genetic Variation [473]
MEF2A OTV2SF6E Limited Altered Expression [474]
MEPE OTXJRUW0 Limited Genetic Variation [475]
MFAP4 OT5W64QY Limited Biomarker [476]
MGAT5 OTU4DD4G Limited Biomarker [477]
MIOX OTDD9G4E Limited Genetic Variation [478]
MMAB OTOWOEJN Limited Biomarker [440]
MNAT1 OTXLOYCB Limited Altered Expression [96]
MNDA OTCTKR47 Limited Altered Expression [286]
MYO1B OTGZUJ0I Limited Genetic Variation [479]
MYO9B OTQ94R5K Limited Biomarker [480]
NCDN OT5CE7LO Limited Altered Expression [451]
NELFCD OTOLTZPU Limited Biomarker [481]
NOC2L OTNT7R33 Limited Biomarker [482]
NOVA1 OT6A9KHY Limited Altered Expression [483]
NPHS1 OT21JD3P Limited Genetic Variation [484]
OGA OT7ZBWT1 Limited Biomarker [485]
OLIG2 OTMCN6D3 Limited Genetic Variation [88]
OR10A4 OTYYB8SY Limited Genetic Variation [278]
OR14J1 OTFIHZ4O Limited Genetic Variation [486]
ORM1 OTZKSBRE Limited Biomarker [459]
PANX1 OTXPEDOK Limited Biomarker [487]
PANX2 OTAQ2S8R Limited Biomarker [487]
PCBP4 OTDLL4NB Limited Biomarker [488]
PCMT1 OTGYVSGU Limited Biomarker [489]
PCSK1N OT7ZRW2F Limited Genetic Variation [490]
PELI1 OTMLBCLC Limited Genetic Variation [491]
PGP OT6QQ7OR Limited Biomarker [492]
PHTF1 OTYCZ84A Limited Genetic Variation [493]
PI3 OT47MTC3 Limited Biomarker [494]
PIP4K2C OTHRWR93 Limited Genetic Variation [138]
PLAAT4 OTI66SAJ Limited Biomarker [495]
PLEK OTB73XXA Limited Biomarker [419]
PLXNA3 OTMZIBVG Limited Altered Expression [496]
PPBP OT1FHGQS Limited Biomarker [115]
PRDM10 OTDDWU5Q Limited Biomarker [497]
PRDM6 OTKY12D9 Limited Genetic Variation [491]
PSMA3 OT52M10V Limited Genetic Variation [162]
PSMA6 OTJ6RPX5 Limited Genetic Variation [162]
PSMC6 OTG8997V Limited Genetic Variation [162]
PSMD7 OT7PZZ4K Limited Altered Expression [142]
PSMD8 OTY6X27P Limited Biomarker [423]
PUM3 OTN1IPNS Limited Genetic Variation [490]
QRSL1 OTJDU2UG Limited Biomarker [498]
RABEPK OTCZSREH Limited Altered Expression [142]
RAC2 OTAOHFNH Limited Genetic Variation [499]
RAG2 OTG9UYTW Limited Biomarker [500]
RASSF7 OT0V4EIZ Limited Biomarker [501]
RBM17 OT9ROJCL Limited Genetic Variation [502]
RELB OTU3QYEF Limited Genetic Variation [503]
RGS1 OTGXJYMG Limited Biomarker [504]
RIT2 OTSNYG0D Limited Biomarker [505]
RMDN1 OTE1NB6U Limited Biomarker [506]
RMDN2 OTK5WSFI Limited Biomarker [506]
RMDN3 OTKO7AUM Limited Biomarker [506]
RNF180 OT2GKIKE Limited Genetic Variation [125]
RTL1 OTOT33IM Limited Genetic Variation [507]
SARS1 OTFKXQ1O Limited Biomarker [508]
SARS2 OTU4T99W Limited Biomarker [508]
SCG5 OTXSJMT1 Limited Biomarker [509]
SELENOS OTUEWIU9 Limited Genetic Variation [510]
SLC35G1 OTKZUA8O Limited Biomarker [441]
SMOC1 OTJG2JQY Limited Genetic Variation [511]
SOCS5 OTN1ABYR Limited Genetic Variation [512]
SP3 OTYDQZ1T Limited Genetic Variation [434]
SPRR2A OT62ZU6B Limited Biomarker [513]
SRSF5 OTC5WP98 Limited Biomarker [352]
STAP2 OTEB1VVI Limited Biomarker [514]
STK17B OT4NYNO8 Limited Biomarker [515]
STPG4 OT5K4UFL Limited Altered Expression [516]
SUV39H2 OTU0F4LL Limited Biomarker [171]
SYBU OT3FQV7N Limited Biomarker [506]
TAGAP OTHJNNO2 Limited Genetic Variation [517]
TAPBP OTL81AVZ Limited Biomarker [166]
TGFBI OTR443C5 Limited Altered Expression [500]
TSPAN33 OTH6C0WU Limited Genetic Variation [490]
TSPAN5 OTHCCHHV Limited Biomarker [317]
TTC3 OTTR9WUC Limited Genetic Variation [88]
ASCC2 OT3B204T Disputed Biomarker [207]
CASZ1 OTWJ2OR8 Disputed Biomarker [382]
CAV2 OT1FGRQX Disputed Biomarker [193]
CD101 OT4QX6BR Disputed Biomarker [518]
CELA3A OT9JAL80 Disputed Altered Expression [255]
CELA3B OTGU8BE9 Disputed Altered Expression [519]
DEFB1 OT5SV0E4 Disputed Biomarker [209]
DLAT OT9LBJVN Disputed Biomarker [520]
GAL3ST1 OTSFFZRD Disputed Biomarker [382]
GDE1 OTU6FSBF Disputed Biomarker [521]
IPPK OT251AAR Disputed Biomarker [522]
ISYNA1 OT49ONSE Disputed Altered Expression [203]
KRT18 OTVLQFIP Disputed Altered Expression [523]
MAP6 OTPUI00F Disputed Genetic Variation [524]
MSC OTBRPZL5 Disputed Biomarker [525]
NFAT5 OTKIE59S Disputed Biomarker [526]
OAS3 OT6E5FYS Disputed Biomarker [207]
OXA1L OTS0BFRD Disputed Biomarker [527]
PLEKHA1 OT66PF24 Disputed Genetic Variation [172]
PMPCA OT5X1G9Q Disputed Genetic Variation [528]
PPIL2 OTL9Y4IO Disputed Genetic Variation [172]
RNASEH1 OTT7L25X Disputed Genetic Variation [529]
RNASET2 OTWY64L7 Disputed Genetic Variation [172]
SART3 OTC1AM7S Disputed Biomarker [207]
SND1 OTT734JN Disputed Biomarker [207]
SOD3 OTIOZQAB Disputed Altered Expression [381]
SPX OTY3G4AR Disputed Altered Expression [530]
STIM2 OTYNXAW0 Disputed Biomarker [193]
TAS2R13 OTSTOX5G Disputed Altered Expression [208]
TNFAIP6 OT1SLUZH Disputed Biomarker [531]
TRIB3 OTG5OS7X Disputed Altered Expression [208]
ACOT7 OT7C68YV moderate Genetic Variation [384]
ACTBL2 OTD6B81U moderate Genetic Variation [384]
ACTG2 OTRDWUO0 moderate Genetic Variation [384]
ADCY7 OTAWMGP3 moderate Genetic Variation [220]
ADGRL2 OTCXD2YR moderate Genetic Variation [220]
ANKRD30A OTJXYAE5 moderate Genetic Variation [220]
ANKRD55 OT62KZII moderate Genetic Variation [220]
ATG16L1 OTEOYC5D moderate Genetic Variation [220]
ATXN2L OTP5M3R9 moderate Genetic Variation [220]
C1orf141 OTASPHL0 moderate Genetic Variation [220]
CARD9 OTJ81AWD moderate Genetic Variation [220]
CD3D OTRBLP0R moderate Biomarker [532]
CD63 OT2UGZA9 moderate Biomarker [533]
CRB1 OTXYUNG0 moderate Genetic Variation [220]
DUOX1 OTQ2AEW0 moderate Genetic Variation [534]
DUOX2 OTU14HCN moderate Genetic Variation [534]
ELP6 OT0T3BLP moderate Genetic Variation [535]
ESD OTUSIBPS moderate Genetic Variation [536]
FADD OTV7GFHH moderate Genetic Variation [537]
FCGR3B OTSLSPZG moderate Biomarker [538]
FGB OT6RKLI9 moderate Genetic Variation [539]
FGF3 OT9PK2SI moderate Genetic Variation [540]
FHL5 OT6C00Z1 moderate Genetic Variation [384]
FNBP1 OTSJ5KKA moderate Genetic Variation [220]
GALNT3 OT7M67WT moderate Genetic Variation [541]
GIMAP5 OTMND7IR moderate Genetic Variation [455]
GIMAP7 OTBZO19Y moderate Genetic Variation [542]
GYS1 OTJZJRWK moderate Biomarker [543]
HLA-E OTX1CTFB moderate Genetic Variation [544]
HOXD8 OTJ5H7AT moderate Genetic Variation [545]
ID3 OTUULW5Z moderate Genetic Variation [546]
IL12RB1 OTM1IJO2 moderate Genetic Variation [547]
LIPC OTZY5SC9 moderate Biomarker [548]
LMOD1 OTZ2MEMG moderate Biomarker [549]
LURAP1L OTSJ29M5 moderate Genetic Variation [220]
MFSD4B OTHHKWRT moderate Altered Expression [550]
MLC1 OTCNZLSP moderate Genetic Variation [551]
MPP1 OTA2ENZQ moderate Altered Expression [552]
NFKBIL1 OTYFTPS0 moderate Genetic Variation [553]
NKD1 OTY3MO97 moderate Genetic Variation [220]
NUDT1 OTZSES3W moderate Genetic Variation [554]
NUP210 OT3BLQ9M moderate Genetic Variation [213]
PIK3R3 OTXGJ8N1 moderate Altered Expression [552]
POLG2 OTDBMZJB moderate Altered Expression [552]
POTEM OT7L2HGH moderate Genetic Variation [384]
PSMD12 OTWICA51 moderate Altered Expression [552]
RAMP2 OTGQXLH5 moderate Altered Expression [555]
REG1B OTSC2133 moderate Biomarker [384]
SCO1 OTC45UGB moderate Genetic Variation [556]
SEC14L3 OTGQ8GWM moderate Altered Expression [557]
ABCF1 OT6Q079J Strong Genetic Variation [239]
ABHD16A OTDS9K1Z Strong Genetic Variation [239]
ACAD8 OT3JI5GB Strong Genetic Variation [558]
ACAN OTUOCW8K Strong Biomarker [559]
ACOXL OTW680HT Strong Genetic Variation [258]
AFF3 OTR0705Z Strong Genetic Variation [258]
ANKS1A OTYZP3MP Strong Genetic Variation [213]
APOM OTI3FQQC Strong Biomarker [560]
ARID4B OTYLPILE Strong Biomarker [561]
BAG6 OT4Z0S2U Strong Genetic Variation [239]
BCL2L15 OTD943W0 Strong Genetic Variation [262]
BNC2 OTU22H9Z Strong Genetic Variation [562]
BTNL2 OTTTEMZA Strong Biomarker [563]
C1QTNF6 OT57EPQC Strong Genetic Variation [258]
C2 OTHMF4YM Strong Genetic Variation [239]
C4A OTXMOYXU Strong Biomarker [564]
C6orf47 OTMKBNDD Strong Genetic Variation [239]
CALD1 OTNJKJ6Q Strong Genetic Variation [565]
CAMSAP2 OT9KXWE7 Strong Genetic Variation [258]
CASP12 OTY2W6FG Strong Biomarker [412]
CBLIF OTNE20WU Strong Altered Expression [566]
CCL4 OT6B8P25 Strong Altered Expression [246]
CHGA OTXYX5JH Strong Biomarker [567]
CIITA OTRJNZFO Strong Biomarker [568]
CLEC16A OTLGV5SV Strong Biomarker [569]
CLEC2D OTVRLKPM Strong Genetic Variation [570]
COL4A2 OTJK1LKN Strong Genetic Variation [213]
COX2 OTTMVBJJ Strong Altered Expression [571]
CP OTM8JE4Y Strong Altered Expression [572]
CSN2 OT22C0PD Strong Genetic Variation [573]
CSNK2B OT2WW7R1 Strong Genetic Variation [239]
CUX2 OTDJTQAJ Strong Genetic Variation [574]
CYBA OT16N9ZO Strong Genetic Variation [575]
DBP OTE0W7LN Strong Biomarker [576]
DDX39B OTEVCFVU Strong Genetic Variation [239]
DNAH2 OT7J5LDI Strong Genetic Variation [131]
DOCK8 OTNQLL21 Strong Biomarker [577]
EFR3B OTVKWU2L Strong Genetic Variation [334]
FCRL3 OTIFXFWL Strong Genetic Variation [578]
FKRP OTMUZ7GH Strong Genetic Variation [334]
FLNB OTPCOYL6 Strong Altered Expression [579]
FLOT1 OT0JPPJZ Strong Genetic Variation [239]
FOXD3 OTXYV6GO Strong Biomarker [580]
FUT2 OTLXM6WI Strong Biomarker [398]
GAB3 OTKX1KEC Strong Genetic Variation [131]
GABBR1 OTU5A52J Strong Genetic Variation [239]
GC OTWS63BY Strong Genetic Variation [348]
GLRA3 OTC8C2NC Strong Genetic Variation [581]
GPANK1 OT1TN2KT Strong Genetic Variation [239]
GPSM3 OT2MO458 Strong Genetic Variation [239]
GPX4 OTRAFFX2 Strong Genetic Variation [400]
GSDMB OTWA7P10 Strong Genetic Variation [582]
H2BC15 OTU39CFZ Strong Genetic Variation [239]
HAVCR1 OT184CRZ Strong Biomarker [583]
HCP5 OTV0YRI8 Strong Genetic Variation [239]
HLA-C OTV38BUJ Strong Biomarker [584]
HLA-DMB OT17HGXJ Strong Genetic Variation [239]
HLA-DOB OTKADDUB Strong Genetic Variation [239]
HLA-DPA1 OT7OG7Y2 Strong Genetic Variation [585]
HLA-DRA OT7KZMP2 Strong Genetic Variation [586]
HLA-DRB4 OTNXIHQU Strong Genetic Variation [587]
HLA-DRB5 OTUX5TWM Strong Genetic Variation [588]
HORMAD2 OTL2ENWI Strong Genetic Variation [258]
HPSE2 OTGEPP8V Strong Genetic Variation [334]
HSPA14 OTZCA5LK Strong Biomarker [589]
HSPA1A OTKGIE76 Strong Biomarker [590]
HSPA1L OTC2V1K6 Strong Genetic Variation [239]
IFNA1 OTPMKY0L Strong Biomarker [591]
IKZF4 OTHGPHOM Strong Genetic Variation [592]
INSM2 OTNMQUZV Strong Biomarker [593]
IRF5 OT8SIIAP Strong Genetic Variation [594]
IRF7 OTC1A2PQ Strong Biomarker [595]
ISG20 OTCWRJJW Strong Genetic Variation [261]
KL OTD4VWU6 Strong Biomarker [596]
LAD1 OT6YGTVX Strong Biomarker [597]
LMO7 OTDLY6TC Strong Genetic Variation [334]
LST1 OTUVG424 Strong Genetic Variation [239]
LY6G5B OTW89R8K Strong Genetic Variation [239]
LY6G5C OTC5GIUX Strong Genetic Variation [239]
LY6G6C OTV7F59X Strong Genetic Variation [239]
LY6G6D OTG75QOC Strong Genetic Variation [239]
MAGI3 OTDJ5QUH Strong Genetic Variation [262]
MPIG6B OTVNKQWA Strong Biomarker [598]
MSH5 OTDARQT3 Strong Genetic Variation [599]
MUC21 OTQ8GP5L Strong Genetic Variation [239]
MUCL3 OTGAD3I0 Strong Genetic Variation [239]
NAA25 OTS3QVF1 Strong Genetic Variation [493]
NEUROG3 OT6DIPWC Strong Genetic Variation [600]
NHS OTKE8QAT Strong Genetic Variation [601]
NRXN1 OTJN1JQA Strong Genetic Variation [602]
NXF1 OTEFHXG6 Strong Altered Expression [579]
OAS1 OT8ZLOCY Strong Genetic Variation [603]
OR12D3 OTQ9XNBB Strong Genetic Variation [239]
OR5V1 OTSYXOD6 Strong Genetic Variation [239]
PDLIM7 OTAZVODU Strong Genetic Variation [604]
PLXNA2 OTNNBJMQ Strong Genetic Variation [605]
POU5F1 OTDHHN7O Strong Genetic Variation [239]
PPP1R18 OT0JVGOZ Strong Genetic Variation [239]
PPT2 OTD5VJ9A Strong Genetic Variation [239]
PRF1 OTFVXD7H Strong Genetic Variation [606]
PRKD2 OTIFSVI8 Strong Genetic Variation [258]
PRPF31 OTSJ0Z1Y Strong Biomarker [607]
PRRT1 OTN0YIS3 Strong Genetic Variation [239]
PRSS16 OTVCZ5V1 Strong Biomarker [427]
PSORS1C1 OT9HK436 Strong Genetic Variation [239]
PTPRU OTHDO0QG Strong Biomarker [385]
RAB5B OT06PN42 Strong Genetic Variation [270]
RAPGEF5 OT53VS75 Strong Biomarker [608]
RASGRP1 OTX9WN2E Strong Genetic Variation [258]
REG1A OTMHUH1D Strong Biomarker [609]
RMI2 OTA0HP4S Strong Genetic Variation [258]
RNF39 OTUQA9JT Strong Genetic Variation [239]
RNF5 OTDQGI37 Strong Genetic Variation [239]
RNLS OTVP2WJM Strong Genetic Variation [258]
RPL17 OTTYMPS6 Strong Genetic Variation [610]
RPS26 OTBYTA6A Strong Genetic Variation [258]
SEC14L2 OTJST64D Strong Altered Expression [579]
SFTA2 OTVRIUIV Strong Genetic Variation [239]
SGF29 OTTE5GOJ Strong Genetic Variation [334]
SHBG OTPWU5IW Strong Biomarker [611]
SIRPG OTE2P8G0 Strong Altered Expression [612]
SKAP2 OTSF44KP Strong Genetic Variation [131]
SORBS1 OTWH8762 Strong Genetic Variation [613]
SPATA2 OTOA45GL Strong Genetic Variation [610]
SPINK1 OTSUVAL2 Strong Genetic Variation [256]
STAT5A OTBSJGN3 Strong Biomarker [614]
STAT5B OTZVPEBT Strong Genetic Variation [615]
STK19 OTYM6437 Strong Genetic Variation [239]
SUOX OTEJQ9FC Strong Genetic Variation [220]
TAB2 OTPZK76F Strong Genetic Variation [616]
TAC3 OTOJGM38 Strong Biomarker [617]
TBP OT6C0S52 Strong Genetic Variation [618]
TCF19 OT7NKLF9 Strong Biomarker [619]
TCF7 OT1ID822 Strong Genetic Variation [620]
TG OT3ELHIJ Strong Biomarker [621]
THEMIS OTXODBXJ Strong Genetic Variation [622]
THY1 OTVONVTB Strong Biomarker [623]
TNXB OTVBWAV5 Strong Genetic Variation [624]
TPGS2 OT25O8ME Strong Altered Expression [625]
TRDN OTXVE9SF Strong Genetic Variation [300]
TRIM31 OT7VW6RP Strong Genetic Variation [262]
TRIM40 OTLKKKA5 Strong Genetic Variation [239]
TSBP1 OT5GE8IO Strong Genetic Variation [239]
ADCY3 OTGOQM6B Definitive Altered Expression [626]
AGA OTNWT1WB Definitive Biomarker [627]
AMPD1 OTU17BCI Definitive Biomarker [628]
ANGPTL8 OTQFINCD Definitive Altered Expression [629]
ARHGAP25 OTYW7ED8 Definitive Biomarker [630]
B4GALT1 OTBCXEK7 Definitive Genetic Variation [631]
BEST1 OTWHE1ZC Definitive Biomarker [341]
CACUL1 OT6P1ZVP Definitive Altered Expression [632]
CCHCR1 OT22C116 Definitive Biomarker [611]
CCNY OTK1KG5W Definitive Genetic Variation [351]
CFHR2 OTACE5Y1 Definitive Biomarker [347]
CILP OTKEY2NJ Definitive Biomarker [633]
CSAD OT3I2G0A Definitive Biomarker [355]
CUL4A OTTBV70J Definitive Biomarker [632]
CUL4B OT2QX4DO Definitive Biomarker [632]
DEAF1 OTCLX3ZW Definitive Biomarker [634]
DEFA1 OT5N1B9B Definitive Biomarker [209]
DIAPH2 OTBEYFEZ Definitive Genetic Variation [635]
DNAH8 OTGES2OU Definitive Genetic Variation [636]
DOC2B OTRUMZ8C Definitive Altered Expression [637]
DSPP OT1TYNDN Definitive Biomarker [638]
EEF2 OTZ7SZ39 Definitive Biomarker [336]
ETFA OTXX61VZ Definitive Biomarker [627]
GOLGA6A OTHU9MRX Definitive Biomarker [639]
GORASP2 OTL3PLD2 Definitive Biomarker [640]
GRB10 OTCKXGRC Definitive Biomarker [641]
HERC2 OTNQYKOB Definitive Genetic Variation [351]
IL17RA OTVVI8ER Definitive Altered Expression [642]
IL26 OT2WYCW4 Definitive Genetic Variation [351]
IL3 OT0CQ35N Definitive Altered Expression [566]
KRT20 OT4RB40L Definitive Biomarker [360]
LEAP2 OTUOPIS5 Definitive Biomarker [643]
LMO3 OTR7AJHN Definitive Biomarker [563]
LYPD5 OTGP7UKA Definitive Altered Expression [644]
MCU OTQZAYWQ Definitive Biomarker [645]
MOK OTQK7M9V Definitive Biomarker [72]
MXD1 OTS5CTHX Definitive Biomarker [628]
NENF OTGL7MHB Definitive Altered Expression [646]
NPB OT0U82T3 Definitive Biomarker [647]
NPW OTO7MT28 Definitive Biomarker [647]
NUDT10 OT61XMYC Definitive Genetic Variation [648]
PDHX OTG7O271 Definitive Biomarker [230]
PF4V1 OT2CXM6L Definitive Genetic Variation [649]
PI16 OTJY2N6U Definitive Biomarker [650]
POF1B OTFWNK8G Definitive Genetic Variation [635]
POLE OTFM3MMU Definitive Altered Expression [651]
PSG1 OT1U4ZZW Definitive Biomarker [652]
PSG7 OT1IXGBX Definitive Biomarker [652]
PSG8 OT00UZBM Definitive Biomarker [652]
RCBTB1 OTAYELI8 Definitive Biomarker [639]
SARDH OTQ49Q27 Definitive Biomarker [653]
SCAF11 OTX59D0X Definitive Biomarker [630]
SDS OT5WTJ2M Definitive Biomarker [119]
SELENBP1 OT3NZNTR Definitive Biomarker [611]
SH2D1A OTLU49I5 Definitive Biomarker [244]
SOSTDC1 OTAKDNSM Definitive Biomarker [654]
SOX13 OTCIF6KC Definitive Biomarker [655]
SRL OT7IEBWZ Definitive Biomarker [653]
ST3GAL4 OTNENJZQ Definitive Biomarker [656]
STX8 OTFOJCHI Definitive Biomarker [657]
SUMO2 OT1Y5IKN Definitive Biomarker [658]
TAT OT2CJ91O Definitive Biomarker [659]
THBS2 OTXET551 Definitive Genetic Variation [660]
TIMP1 OTOXC51H Definitive Biomarker [661]
TTC4 OTAPMYXU Definitive Biomarker [662]
------------------------------------------------------------------------------------
⏷ Show the Full List of 471 DOT(s)

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of Lundbeck.
3 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4754).
4 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
5 Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes. N Engl J Med. 2022 Sep 29;387(13):1161-1172.
6 Pentoxifylline FDA Label
7 ClinicalTrials.gov (NCT01359943) Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
8 FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761183.
9 NNZ-2566 treatment inhibits neuroinflammation and pro-inflammatory cytokine expression induced by experimental penetrating ballistic-like brain injury in rats. J Neuroinflammation. 2009 Aug 5;6:19.
10 ClinicalTrials.gov (NCT00515632) Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy. U.S. National Institutes of Health.
11 ClinicalTrials.gov (NCT00751842) A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT. U.S. National Institutes of Health.
12 ClinicalTrials.gov (NCT03791567) Islet Transplantation in Type I Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol. U.S. National Institutes of Health.
13 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2672).
14 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
15 Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study. J Am Acad Dermatol. 2014 Sep;71(3):484-92.
16 ClinicalTrials.gov (NCT01483898) An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI). U.S. National Institutes of Health.
17 Clinical pipeline report, company report or official report of Novo Nordisk A/S.
18 ClinicalTrials.gov (NCT00668850) Active Comparator Study of Generex Oral-lyn Spray and Injected Human Insulin. U.S. National Institutes of Health.
19 ClinicalTrials.gov (NCT00411892) Effect of Inhaled Insulin (AERx iDMS) on Blood Glucose Control in Type 2 Diabetes. U.S. National Institutes of Health.
20 The Hsp60 peptide p277 enhances anti-CD3 mediated diabetes remission in non-obese diabetic mice. J Autoimmun. 2015 May;59:61-6.
21 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2664).
22 ClinicalTrials.gov (NCT01018173) A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease. U.S. National Institutes of Health.
23 ClinicalTrials.gov (NCT00229710) GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes. U.S. National Institutes of Health.
24 ClinicalTrials.gov (NCT01686620) A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog). U.S. National Institutes of Health.
25 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
26 ClinicalTrials.gov (NCT04129528) Investigator- and Subject-blinded, Randomized, Placebo-controlled Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy Trial of CFZ533 in Pediatric and Young Adult Subjects With New Onset Type 1 Diabetes (T1DM). U.S.National Institutes of Health.
27 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034087)
28 ClinicalTrials.gov (NCT00464555) Strategies to Improve Islet Survival. U.S. National Institutes of Health.
29 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8458).
30 ClinicalTrials.gov (NCT03117998) Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus. U.S. National Institutes of Health.
31 Clinical pipeline report, company report or official report of Tolerion.
32 ClinicalTrials.gov (NCT00743002) A Trial of TT223 in Patients With Type 2 Diabetes Who Are Taking Metformin and/or Thiazolidinedione. U.S. National Institutes of Health.
33 ClinicalTrials.gov (NCT03335371) Evaluation of TTP399 in Patients With Type 1 Diabetes (SimpliciT1). U.S. National Institutes of Health.
34 ClinicalTrials.gov (NCT04956263) A Comparison of Postprandial Glucose After a Mixed Meal Tolerance Test, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study of the Dual Systemic SGLT1 and SGLT2 Inhibitor YG1699, and the Selective SGLT2 Inhibitor Dapagliflozin in Subjects With Type 1 Diabetes. U.S.National Institutes of Health.
35 ClinicalTrials.gov (NCT03751007) A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D). U.S. National Institutes of Health.
36 ClinicalTrials.gov (NCT03895996) A Phase 1 / 2 Double-Blind, Randomized, Placebo Controlled Study of Safety, Tolerability and Potential Efficacy of AVOTRES Cell-Based Therapy (AVT001) in Patients With Type 1 Diabetes. U.S.National Institutes of Health.
37 ClinicalTrials.gov (NCT00260234) Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients. U.S. National Institutes of Health.
38 Transplantation of Encapsulated Pancreatic Islets as a Treatment for Patients with Type 1 Diabetes Mellitus. Advances in Medicine. Volume 2014 (2014), Article ID 429710, 15 pages
39 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019847)
40 ClinicalTrials.gov (NCT02239354) A Safety, Tolerability, and Efficacy Study of VC-01 Combination Product in Subjects With Type I Diabetes Mellitus
41 ClinicalTrials.gov (NCT02193334) Phase I/II Study of KP-100IT in Acute Spinal Cord Injury. U.S. National Institutes of Health.
42 ClinicalTrials.gov (NCT03163511) An Open-Label, First-In-Human Study Evaluating the Safety, Tolerability, and Efficacy of VC-02? Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness. U.S.National Institutes of Health.
43 ClinicalTrials.gov (NCT04678557) An Open-Label Phase 1/2 Study to Evaluate the Safety, Engraftment, and Efficacy of VC-01?Combination Product in Subjects With Type 1 Diabetes Mellitus [T1DM]. U.S.National Institutes of Health.
44 ClinicalTrials.gov (NCT01053728) Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM). U.S. National Institutes of Health.
45 ClinicalTrials.gov (NCT04786262) A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia. U.S.National Institutes of Health.
46 ClinicalTrials.gov (NCT00453375) Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus. U.S. National Institutes of Health.
47 Clinical pipeline report, company report or official report of Boston Therapeutics.
48 ClinicalTrials.gov (NCT00057499) Evaluation of a Diabetes Vaccine in Newly Diagnosed Diabetics. U.S. National Institutes of Health.
49 ClinicalTrials.gov (NCT04625595) A Phase 1b, Randomized, Single-blind, Placebo-controlled, Multiple Ascending Dose (MAD) Study to Assess the Steady-State Pharmacokinetics and DQ8 Blocking Efficacy of Orally Administered IMT-002 in Patients With Type 1 Diabetes and HLA-DQ8. U.S.National Institutes of Health.
50 Prevention of Type 1 Diabetes Mellitus using a Novel Vaccine. Ther Adv Endocrinol Metab. 2011 February; 2(1): 9-16.
51 Clinical pipeline report, company report or official report of Biodel.
52 ClinicalTrials.gov (NCT03170544) Single Ascending Dose Study of MK-1092 in Healthy Participants and in Participants With Type 1 and Type 2 Diabetes Mellitus (MK-1092-001). U.S. National Institutes of Health.
53 ClinicalTrials.gov (NCT02528799) Safety and Tolerability of Nexvax2 in Subjects With Celiac Disease.
54 ClinicalTrials.gov (NCT00400283) A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes. U.S. National Institutes of Health.
55 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037233)
56 Alize Pharma announces positive results for AZP-531, its unacylated ghrelin analog, from two Phase I clinical trials in healthy volunteers and obese subjects. Lyon, France, December 10, 2014.
57 ClinicalTrials.gov (NCT05210530) An Open-Label, First-In-Human Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With Type 1 Diabetes Mellitus (T1D). U.S.National Institutes of Health.
58 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2687).
59 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011739)
60 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015896)
61 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011773)
62 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010082)
63 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016001)
64 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022421)
65 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015749)
66 The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
67 Alterations of ADAMTSs and TIMP-3 in human nucleus pulposus cells subjected to compressive load: Implications in the pathogenesis of human intervertebral disc degeneration.J Orthop Res. 2012 Feb;30(2):267-73. doi: 10.1002/jor.21507. Epub 2011 Aug 1.
68 Leptin downregulates aggrecan through the p38-ADAMST pathway in human nucleus pulposus cells.PLoS One. 2014 Oct 9;9(10):e109595. doi: 10.1371/journal.pone.0109595. eCollection 2014.
69 Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis.Immunol Res. 2014 May;58(2-3):340-50. doi: 10.1007/s12026-014-8501-8.
70 Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.J Mol Cell Cardiol. 2016 Jan;90:30-7. doi: 10.1016/j.yjmcc.2015.11.033. Epub 2015 Dec 2.
71 The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus).Diabetologia. 2011 Jul;54(7):1831-40. doi: 10.1007/s00125-011-2138-0. Epub 2011 Apr 15.
72 Dietary advanced glycated end-products and medicines influence the expression of SIRT1 and DDOST in peripheral mononuclear cells from long-term type 1 diabetes patients.Diab Vasc Dis Res. 2018 Jan;15(1):81-89. doi: 10.1177/1479164117733918. Epub 2017 Oct 13.
73 Microvascular vasodilator properties of the angiotensin II type 2 receptor in a mouse model of type 1 diabetes.Sci Rep. 2017 Mar 31;7:45625. doi: 10.1038/srep45625.
74 Increased Indoleamine 2,3-Dioxygenase and Quinolinic Acid Expression in Microglia and Mller Cells of Diabetic Human and Rodent Retina.Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5043-5055. doi: 10.1167/iovs.17-21654.
75 The Four-Way Stop Sign: Viruses, 12-Lipoxygenase, Islets, and Natural Killer Cells in Type 1 Diabetes Progression.Front Endocrinol (Lausanne). 2017 Sep 25;8:246. doi: 10.3389/fendo.2017.00246. eCollection 2017.
76 Amylase alpha-2A autoantibodies: novel marker of autoimmune pancreatitis and fulminant type 1 diabetes.Diabetes. 2009 Mar;58(3):732-7. doi: 10.2337/db08-0493. Epub 2008 Nov 10.
77 Association between plasma activities of semicarbazide-sensitive amine oxidase and angiotensin-converting enzyme in patients with type 1 diabetes mellitus.Diabetologia. 2005 May;48(5):1002-7. doi: 10.1007/s00125-005-1716-4. Epub 2005 Apr 14.
78 The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes.Diabetologia. 2006 Aug;49(8):1946-54. doi: 10.1007/s00125-006-0317-1. Epub 2006 Jun 13.
79 Is APOC3 the driver of cardiovascular disease in people with type I diabetes mellitus?.J Clin Invest. 2019 Oct 1;129(10):4074-4076. doi: 10.1172/JCI131333.
80 Molecular mechanism of the increased tissue uptake of trivalent inorganic arsenic in mice with type 1 diabetes mellitus.Biochem Biophys Res Commun. 2018 Oct 2;504(2):393-399. doi: 10.1016/j.bbrc.2018.06.029. Epub 2018 Jun 19.
81 Inhibition of Rho kinase protects from ischaemia-reperfusion injury via regulation of arginase activity and nitric oxide synthase in type 1 diabetes.Diab Vasc Dis Res. 2017 May;14(3):236-245. doi: 10.1177/1479164116687935. Epub 2017 Feb 9.
82 Downregulation of microRNA-125a is involved in intervertebral disc degeneration by targeting pro-apoptotic Bcl-2 antagonist killer 1.Iran J Basic Med Sci. 2017 Nov;20(11):1260-1267. doi: 10.22038/IJBMS.2017.9542.
83 Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction.J Rheumatol. 2011 Sep;38(9):1866-70. doi: 10.3899/jrheum.110199. Epub 2011 Jul 15.
84 Association study between B- and T-lymphocyte attenuator gene and type 1 diabetes mellitus or systemic lupus erythematosus in the Japanese population.Int J Immunogenet. 2009 Feb;36(1):65-8. doi: 10.1111/j.1744-313X.2008.00809.x.
85 Down-regulation of islet amyloid polypeptide expression induces death of human annulus fibrosus cells via mitochondrial and death receptor pathways.Biochim Biophys Acta Mol Basis Dis. 2017 Jun;1863(6):1479-1491. doi: 10.1016/j.bbadis.2017.04.016. Epub 2017 Apr 19.
86 Fas/FasL-mediated cell death in rat's diabetic hearts involves activation of calcineurin/NFAT4 and is potentiated by a high-fat diet rich in corn oil.J Nutr Biochem. 2019 Jun;68:79-90. doi: 10.1016/j.jnutbio.2019.03.007. Epub 2019 Mar 28.
87 Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat.J Immunol. 2006 Nov 15;177(10):7275-86. doi: 10.4049/jimmunol.177.10.7275.
88 Fine mapping of a region on chromosome 21q21.11-q22.3 showing linkage to type 1 diabetes.J Med Genet. 2005 Jan;42(1):17-25. doi: 10.1136/jmg.2004.022004.
89 Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes.Diabetologia. 2011 May;54(5):1136-46. doi: 10.1007/s00125-011-2064-1. Epub 2011 Feb 22.
90 DC-SIGN polymorphisms are associated to type 1 diabetes mellitus.Immunobiology. 2014 Nov;219(11):859-65. doi: 10.1016/j.imbio.2014.07.011. Epub 2014 Jul 22.
91 Soluble B7-H3 (sB7-H3) is over-expressed in the serum of type 1 diabetes patients.Diabetes Res Clin Pract. 2018 Sep;143:332-336. doi: 10.1016/j.diabres.2018.08.004. Epub 2018 Aug 4.
92 Possible association of the CD4 gene polymorphism with vitiligo in an Iranian population.Clin Exp Dermatol. 2010 Jul;35(5):521-4. doi: 10.1111/j.1365-2230.2009.03667.x. Epub 2009 Oct 19.
93 T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10.Nat Immunol. 2013 Jul;14(7):741-8. doi: 10.1038/ni.2610. Epub 2013 May 19.
94 Type 1 diabetes: Developing the first risk-estimation model for predicting silent myocardial ischemia. The potential role of insulin resistance.PLoS One. 2017 Apr 3;12(4):e0174640. doi: 10.1371/journal.pone.0174640. eCollection 2017.
95 Risk of type 1 diabetes in childhood and maternal age at delivery, interaction with ACP1 and sex.Diabetes Metab Res Rev. 2005 Jul-Aug;21(4):353-8. doi: 10.1002/dmrr.521.
96 Impaired processing and presentation by MHC class II proteins in human diabetic cells.J Immunol. 2003 Jan 1;170(1):620-7. doi: 10.4049/jimmunol.170.1.620.
97 High-density lipoprotein cholesterol is related to the TaqIB cholesteryl ester transfer protein gene polymorphism and smoking, but not to moderate alcohol consumption in insulin-dependent diabetic men.Scand J Clin Lab Invest. 1998 May;58(3):251-8. doi: 10.1080/00365519850186643.
98 Increase of cardiac M2-muscarinic receptor gene expression in type-1 but not in type-2 diabetic rats.Neurosci Lett. 2008 Aug 22;441(2):201-4. doi: 10.1016/j.neulet.2008.06.003. Epub 2008 Jun 5.
99 Endurance training reverts heart mitochondrial dysfunction, permeability transition and apoptotic signaling in long-term severe hyperglycemia.Mitochondrion. 2011 Jan;11(1):54-63. doi: 10.1016/j.mito.2010.07.005. Epub 2010 Jul 21.
100 Aerobic exercise training decreases cereblon and increases AMPK signaling in the skeletal muscle of STZ-induced diabetic rats.Biochem Biophys Res Commun. 2018 Jun 22;501(2):448-453. doi: 10.1016/j.bbrc.2018.05.009. Epub 2018 May 10.
101 Targeted Deep Sequencing in Multiple-Affected Sibships of European Ancestry Identifies Rare Deleterious Variants in PTPN22 That Confer Risk for Type 1 Diabetes.Diabetes. 2016 Mar;65(3):794-802. doi: 10.2337/db15-0322. Epub 2015 Dec 2.
102 Downregulation of cathepsin G reduces the activation of CD4+ T cells in murine autoimmune diabetes.Am J Transl Res. 2017 Nov 15;9(11):5127-5137. eCollection 2017.
103 Integration of disease association and eQTL data using a Bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases.Hum Mol Genet. 2015 Jun 15;24(12):3305-13. doi: 10.1093/hmg/ddv077. Epub 2015 Mar 5.
104 Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis.Hum Immunol. 2007 Sep;68(9):748-55. doi: 10.1016/j.humimm.2007.05.009. Epub 2007 Jun 28.
105 The role of cubilin gene polymorphisms and their influence on 25(OH)D3 and 1,25(OH)2D3 plasma levels in type 1 diabetes patients.J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):442-4. doi: 10.1016/j.jsbmb.2010.03.087. Epub 2010 Apr 14.
106 Eukaryotic translation initiation factor 5A inhibition alters physiopathology and immune responses in a "humanized" transgenic mouse model of type 1 diabetes.Am J Physiol Endocrinol Metab. 2014 Apr 1;306(7):E791-8. doi: 10.1152/ajpendo.00537.2013. Epub 2014 Feb 4.
107 Blunting of the immediate-early gene and mitogenic response in hepatectomized type 1 diabetic animals.Am J Physiol. 1995 Oct;269(4 Pt 1):E691-700. doi: 10.1152/ajpendo.1995.269.4.E691.
108 E2f1 mutation induces early onset of diabetes and Sjgren's syndrome in nonobese diabetic mice.J Immunol. 2004 Oct 15;173(8):4908-18. doi: 10.4049/jimmunol.173.8.4908.
109 The Association between rs2292239 Polymorphism in ERBB3 Gene and Type 1 Diabetes: A Meta-Analysis.Biomed Res Int. 2019 Aug 6;2019:7689642. doi: 10.1155/2019/7689642. eCollection 2019.
110 Targeting ABL-IRE1 Signaling Spares ER-Stressed Pancreatic Cells to Reverse Autoimmune Diabetes.Cell Metab. 2017 Apr 4;25(4):883-897.e8. doi: 10.1016/j.cmet.2017.03.018.
111 Urinary liver-type fatty acid binding protein is an independent predictor of stroke and mortality in individuals with type 1 diabetes.Diabetologia. 2017 Sep;60(9):1782-1790. doi: 10.1007/s00125-017-4328-x. Epub 2017 Jun 10.
112 Materno-Fetal Transfer of Preproinsulin Through the Neonatal Fc Receptor Prevents Autoimmune Diabetes.Diabetes. 2015 Oct;64(10):3532-42. doi: 10.2337/db15-0024. Epub 2015 Apr 27.
113 Free fatty acid receptor 2, a candidate target for type 1 diabetes, induces cell apoptosis through ERK signaling.J Mol Endocrinol. 2014 Dec;53(3):367-80. doi: 10.1530/JME-14-0065. Epub 2014 Oct 8.
114 FGF21 and glycemic control in patients with T1D.Endocrine. 2019 Sep;65(3):550-557. doi: 10.1007/s12020-019-02027-3. Epub 2019 Aug 1.
115 Bioinformatics analysis of gene expression in peripheral blood mononuclear cells from children with type 1 diabetes in 3 periods.Exp Clin Endocrinol Diabetes. 2014 Sep;122(8):477-83. doi: 10.1055/s-0034-1372599. Epub 2014 May 16.
116 A method for gene-based pathway analysis using genomewide association study summary statistics reveals nine new type 1 diabetes associations.Genet Epidemiol. 2014 Dec;38(8):661-70. doi: 10.1002/gepi.21853. Epub 2014 Nov 4.
117 Capsaicin Reduces Blood Glucose by Increasing Insulin Levels and Glycogen Content Better than Capsiate in Streptozotocin-Induced Diabetic Rats.J Agric Food Chem. 2017 Mar 22;65(11):2323-2330. doi: 10.1021/acs.jafc.7b00132. Epub 2017 Mar 2.
118 Detection and Characterization of CD8(+) Autoreactive Memory Stem T Cells in Patients With Type 1 Diabetes.Diabetes. 2018 May;67(5):936-945. doi: 10.2337/db17-1390. Epub 2018 Mar 5.
119 Efficacy of Growth Hormone Treatment in Children with Type 1 Diabetes Mellitus and Growth Hormone Deficiency-An Analysis of KIGS Data.J Pediatr. 2018 Jul;198:260-264. doi: 10.1016/j.jpeds.2018.02.035. Epub 2018 Apr 12.
120 Associations of serum glucagon levels with glycemic variability in type 1 diabetes with different disease durations.Endocrine. 2018 Sep;61(3):473-481. doi: 10.1007/s12020-018-1641-1. Epub 2018 Jun 18.
121 Statistical colocalization of monocyte gene expression and genetic risk variants for type 1 diabetes.Hum Mol Genet. 2012 Jun 15;21(12):2815-24. doi: 10.1093/hmg/dds098. Epub 2012 Mar 8.
122 Screening for Type 1 Diabetes Risk in Newborns: The Freder1k Pilot Study in Saxony.Horm Metab Res. 2018 Jan;50(1):44-49. doi: 10.1055/s-0043-120921. Epub 2017 Nov 9.
123 HMGCS2 is a key ketogenic enzyme potentially involved in type 1 diabetes with high cardiovascular risk.Sci Rep. 2017 Jul 4;7(1):4590. doi: 10.1038/s41598-017-04469-z.
124 HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes.Biochem Biophys Res Commun. 2009 Aug 14;386(1):192-6. doi: 10.1016/j.bbrc.2009.06.009. Epub 2009 Jun 9.
125 HTR1A a novel type 1 diabetes susceptibility gene on chromosome 5p13-q13.PLoS One. 2012;7(5):e35439. doi: 10.1371/journal.pone.0035439. Epub 2012 May 1.
126 The dual role of autoimmune regulator in maintaining normal expression level of tissue-restricted autoantigen in the thymus: A modeling investigation.Math Biosci. 2017 May;287:12-23. doi: 10.1016/j.mbs.2016.10.002. Epub 2016 Oct 17.
127 IFN-gamma affects homing of diabetogenic T cells.J Immunol. 2001 Dec 1;167(11):6637-43. doi: 10.4049/jimmunol.167.11.6637.
128 Polymorphism discovery and association analyses of the interferon genes in type 1 diabetes.BMC Genet. 2006 Feb 22;7:12. doi: 10.1186/1471-2156-7-12.
129 VSEAMS: a pipeline for variant set enrichment analysis using summary GWAS data identifies IKZF3, BATF and ESRRA as key transcription factors in type 1 diabetes.Bioinformatics. 2014 Dec 1;30(23):3342-8. doi: 10.1093/bioinformatics/btu571. Epub 2014 Aug 27.
130 On the Role IL-4/IL-13 Heteroreceptor Plays in Regulation of Type 1 Diabetes.J Immunol. 2017 Aug 1;199(3):894-902. doi: 10.4049/jimmunol.1700410. Epub 2017 Jun 23.
131 Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.Nat Genet. 2009 Jun;41(6):703-7. doi: 10.1038/ng.381. Epub 2009 May 10.
132 FokI polymorphism, vitamin D receptor, and interleukin-1 receptor haplotypes are associated with type 1 diabetes in the Dalmatian population.J Mol Diagn. 2005 Nov;7(5):600-4. doi: 10.1016/S1525-1578(10)60593-4.
133 Homing receptor expression is deviated on CD56+ blood lymphocytes during pregnancy in Type 1 diabetic women.PLoS One. 2015 Mar 20;10(3):e0119526. doi: 10.1371/journal.pone.0119526. eCollection 2015.
134 Molecular scanning of interleukin-21 gene and genetic susceptibility to type 1 diabetes.Hum Immunol. 2007 May;68(5):384-91. doi: 10.1016/j.humimm.2007.01.009. Epub 2007 Feb 21.
135 Association of genetic polymorphisms of interleukins with new-onset diabetes after transplantation in renal transplantation.Transplantation. 2012 May 15;93(9):900-7. doi: 10.1097/TP.0b013e3182497534.
136 IRAK-M deficiency promotes the development of type 1 diabetes in NOD mice.Diabetes. 2014 Aug;63(8):2761-75. doi: 10.2337/db13-1504. Epub 2014 Apr 2.
137 CD11a/ICAM-1 blockade combined with IL-2 targeting therapy causes a paradoxical acceleration of type 1 diabetes.Immunol Cell Biol. 2017 Oct;95(9):803-813. doi: 10.1038/icb.2017.49. Epub 2017 Jun 14.
138 Analysis of 17 autoimmune disease-associated variants in type 1 diabetes identifies 6q23/TNFAIP3 as a susceptibility locus.Genes Immun. 2009 Mar;10(2):188-91. doi: 10.1038/gene.2008.99. Epub 2008 Dec 25.
139 Association between KIR gene polymorphisms and type 1 diabetes mellitus (T1DM) susceptibility: A PRISMA-compliant meta-analysis.Medicine (Baltimore). 2017 Dec;96(52):e9439. doi: 10.1097/MD.0000000000009439.
140 Investigation of activating and inhibitory killer cell immunoglobulin-like receptors and their putative ligands in type 1 diabetes (T1D).Hum Immunol. 2016 Jan;77(1):110-114. doi: 10.1016/j.humimm.2015.10.019. Epub 2015 Nov 2.
141 KLRG1 expression identifies short-lived Foxp3(+) T(reg) effector cells with functional plasticity in islets of NOD mice.Autoimmunity. 2017 Sep;50(6):354-362. doi: 10.1080/08916934.2017.1364368. Epub 2017 Aug 29.
142 Alleles of the IL12B 3'UTR associate with late onset of type 1 diabetes.Hum Immunol. 2004 Dec;65(12):1432-6. doi: 10.1016/j.humimm.2004.09.001.
143 Integrating genome-wide genetic variations and monocyte expression data reveals trans-regulated gene modules in humans.PLoS Genet. 2011 Dec;7(12):e1002367. doi: 10.1371/journal.pgen.1002367. Epub 2011 Dec 1.
144 The MAPK kinase kinase-1 is essential for stress-induced pancreatic islet cell death.Endocrinology. 2008 Jun;149(6):3046-53. doi: 10.1210/en.2007-0438. Epub 2008 Feb 28.
145 CHOP Deficiency Ameliorates ERK5 Inhibition-Mediated Exacerbation of Streptozotocin-Induced Hyperglycemia and Pancreatic -Cell Apoptosis.Mol Cells. 2017 Jul 31;40(7):457-465. doi: 10.14348/molcells.2017.2296. Epub 2017 Jul 6.
146 Upregulation of ACE2-ANG-(1-7)-Mas axis in jejunal enterocytes of type 1 diabetic rats: implications for glucose transport.Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E669-81. doi: 10.1152/ajpendo.00562.2011. Epub 2012 Jul 17.
147 Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes.Diabetes Metab Res Rev. 2017 Jul;33(5). doi: 10.1002/dmrr.2895. Epub 2017 Apr 11.
148 Family studies of type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms.Genes Immun. 2014 Apr;15(4):218-23. doi: 10.1038/gene.2014.7. Epub 2014 Feb 27.
149 Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients.Diabetologia. 2013 Dec;56(12):2743-52. doi: 10.1007/s00125-013-3052-4.
150 Insulin upregulates GRIM-19 and protects cardiac mitochondrial morphology in type 1 diabetic rats partly through PI3K/AKT signaling pathway.Biochem Biophys Res Commun. 2017 Nov 4;493(1):611-617. doi: 10.1016/j.bbrc.2017.08.144. Epub 2017 Sep 1.
151 Genome-wide pathway analysis for diabetic nephropathy in type 1 diabetes.Endocr Res. 2016;41(1):21-7. doi: 10.3109/07435800.2015.1044011. Epub 2015 Jul 13.
152 Understanding Autoimmune Diabetes through the Prism of the Tri-Molecular Complex.Front Endocrinol (Lausanne). 2017 Dec 14;8:351. doi: 10.3389/fendo.2017.00351. eCollection 2017.
153 The Association of CEP135 rs4865047 and NPY2R rs1902491 Single Nucleotide Polymorphisms (SNPs) with Rapid Progression of Proliferative Diabetic Retinopathy in Patients with Type 1 Diabetes Mellitus.Med Sci Monit. 2018 Dec 8;24:8891-8898. doi: 10.12659/MSM.909803.
154 A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes.Genes Immun. 2012 Oct;13(7):549-55. doi: 10.1038/gene.2012.36. Epub 2012 Aug 30.
155 Familial Sotos syndrome caused by a novel missense mutation, C2175S, in NSD1 and associated with normal intelligence, insulin dependent diabetes, bronchial asthma, and lipedema.Eur J Med Genet. 2009 Sep-Oct;52(5):306-10. doi: 10.1016/j.ejmg.2009.06.001. Epub 2009 Jun 21.
156 Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes.J Autoimmun. 2009 Sep;33(2):155-64. doi: 10.1016/j.jaut.2009.04.003. Epub 2009 May 26.
157 Evaluation of IDDM8 susceptibility locus in a Russian simplex family data set.J Autoimmun. 2005 May;24(3):243-50. doi: 10.1016/j.jaut.2005.01.017.
158 Polymorphisms in perilipin gene (PLIN) are not associated with obesity and weight variation in people with high risk of type 2 diabetes.Exp Clin Endocrinol Diabetes. 2008 Sep;116 Suppl 1:S56-8. doi: 10.1055/s-2008-1081493. Epub 2008 Sep 5.
159 Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity.Obesity (Silver Spring). 2013 Sep;21(9):1935-41. doi: 10.1002/oby.20327. Epub 2013 May 29.
160 Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice.Antioxid Redox Signal. 2010 Nov 15;13(10):1477-90. doi: 10.1089/ars.2010.3137.
161 Type 1 diabetes genes and pathways shared by humans and NOD mice.J Autoimmun. 2005;25 Suppl:29-33. doi: 10.1016/j.jaut.2005.09.009. Epub 2005 Oct 28.
162 Genetic variations in the PSMA3, PSMA6 and PSMC6 genes are associated with type 1 diabetes in Latvians and with expression level of number of UPS-related and T1DM-susceptible genes in HapMap individuals.Mol Genet Genomics. 2016 Apr;291(2):891-903. doi: 10.1007/s00438-015-1153-0. Epub 2015 Dec 12.
163 Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes.Diabetologia. 2017 Dec;60(12):2514-2524. doi: 10.1007/s00125-017-4415-z. Epub 2017 Sep 5.
164 Non-dipping and arterial hypertension depend on clinical factors rather than on genetic variability of ACE and RGS2 genes in patients with type 1 diabetes.Acta Diabetol. 2014 Aug;51(4):633-40. doi: 10.1007/s00592-014-0568-0. Epub 2014 Feb 23.
165 Temporal profiling of cytokine-induced genes in pancreatic -cells by meta-analysis and network inference.Genomics. 2014 Apr;103(4):264-75. doi: 10.1016/j.ygeno.2013.12.007. Epub 2014 Jan 24.
166 Sequence variation within the major histocompatibility complex subregion centromeric of HLA class II in type 1 diabetes.Tissue Antigens. 2007 Apr;69(4):348-53. doi: 10.1111/j.1399-0039.2007.00820.x.
167 Streptozocin-induced type-1 diabetes mellitus results in decreased density of CGRP sensory and TH sympathetic nerve fibers that are positively correlated with bone loss at the mouse femoral neck.Neurosci Lett. 2017 Aug 10;655:28-34. doi: 10.1016/j.neulet.2017.06.042. Epub 2017 Jun 23.
168 Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation.Diabetologia. 2004 Mar;47(3):537-540. doi: 10.1007/s00125-004-1352-4. Epub 2004 Feb 13.
169 Proportion of daily capillary blood glucose readings required in the target range for target glycaemic control: shift of focus from target range to proportion in range.Diabet Med. 2017 Oct;34(10):1456-1460. doi: 10.1111/dme.13438. Epub 2017 Aug 15.
170 Pursuing type 1 diabetes mellitus and related complications through urinary proteomics.Transl Res. 2014 Mar;163(3):188-99. doi: 10.1016/j.trsl.2013.09.005. Epub 2013 Oct 3.
171 Genetic examination of SETD7 and SUV39H1/H2 methyltransferases and the risk of diabetes complications in patients with type 1 diabetes.Diabetes. 2011 Nov;60(11):3073-80. doi: 10.2337/db11-0073. Epub 2011 Sep 6.
172 Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.J Autoimmun. 2018 May;89:90-100. doi: 10.1016/j.jaut.2017.12.008. Epub 2018 Jan 5.
173 Thiamine-responsive megaloblastic anemia (TRMA) in an Austrian boy with compound heterozygous SLC19A2 mutations.Eur J Pediatr. 2012 Nov;171(11):1711-5. doi: 10.1007/s00431-012-1730-8. Epub 2012 May 11.
174 Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension.Ann Med. 2010 May 6;42(4):296-304. doi: 10.3109/07853891003777109.
175 Glucose transporters in healthy heart and in cardiac disease.Int J Cardiol. 2017 Mar 1;230:70-75. doi: 10.1016/j.ijcard.2016.12.083. Epub 2016 Dec 21.
176 Impact of pre-gestational and gestational diabetes mellitus on the expression of glucose transporters GLUT-1, GLUT-4 and GLUT-9 in human term placenta.Endocrine. 2017 Mar;55(3):799-808. doi: 10.1007/s12020-016-1202-4. Epub 2016 Dec 16.
177 SNPs in the exons of Toll-like receptors are associated with susceptibility to type 1 diabetes in Chinese population.Hum Immunol. 2014 Nov;75(11):1084-8. doi: 10.1016/j.humimm.2014.09.008. Epub 2014 Sep 26.
178 Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas.APMIS. 2017 Feb;125(2):85-92. doi: 10.1111/apm.12632. Epub 2016 Dec 28.
179 Diminished expression of ICOS, GITR and CTLA-4 at the mRNA level in T regulatory cells of children with newly diagnosed type 1 diabetes.Acta Biochim Pol. 2009;56(2):361-70. Epub 2009 Jun 20.
180 Alteration of B cell subsets and the receptor for B cell activating factor (BAFF) in paediatric patients with type 1 diabetes.Immunol Lett. 2017 Sep;189:94-100. doi: 10.1016/j.imlet.2017.04.009. Epub 2017 Apr 14.
181 Type 1 diabetes patients born to immigrants to Sweden increase their native diabetes risk and differ from Swedish patients in HLA types and islet autoantibodies.Pediatr Diabetes. 2010 Dec;11(8):513-20. doi: 10.1111/j.1399-5448.2010.00637.x.
182 Selection of hprt mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitus.Clin Immunol. 1999 Mar;90(3):340-51. doi: 10.1006/clim.1998.4664.
183 Roles of TREM2 in degeneration of human nucleus pulposus cells via NF-B p65.J Cell Biochem. 2018 Nov;119(11):8784-8796. doi: 10.1002/jcb.27126. Epub 2018 Aug 4.
184 Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes.Nat Genet. 2018 Oct;50(10):1366-1374. doi: 10.1038/s41588-018-0216-7. Epub 2018 Sep 17.
185 Identification of the potential molecular targets for human intervertebral disc degeneration based on bioinformatic methods.Int J Mol Med. 2015 Dec;36(6):1593-600. doi: 10.3892/ijmm.2015.2389. Epub 2015 Oct 22.
186 Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes.Diabetes Care. 2006 Jan;29(1):89-94. doi: 10.2337/diacare.29.01.06.dc05-0757.
187 Molecular basis of bilirubin UDP-glucuronosyltransferase induction in spontaneously diabetic rats, acetone-treated rats and starved rats.Biochem J. 1998 Dec 15;336 ( Pt 3)(Pt 3):587-92. doi: 10.1042/bj3360587.
188 G/T substitution in intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes.Diabetes. 2008 Oct;57(10):2843-50. doi: 10.2337/db08-0073. Epub 2008 Jul 15.
189 Humanized Mouse Model to Study Type 1 Diabetes.Diabetes. 2018 Sep;67(9):1816-1829. doi: 10.2337/db18-0202. Epub 2018 Jul 2.
190 Association of TCR/CD3, PTPN22, CD28 and ZAP70 gene polymorphisms with type 1 diabetes risk in Tunisian population: family based association study.Immunol Lett. 2015 Jan;163(1):1-7. doi: 10.1016/j.imlet.2014.11.005. Epub 2014 Nov 18.
191 ATP4A autoimmunity in pediatric patients with type 1 diabetes and its relationship to blood count, iron metabolism, and vitamin B12.Pediatr Diabetes. 2018 Feb;19(1):80-84. doi: 10.1111/pedi.12528. Epub 2017 Apr 12.
192 Screening of monogenic autoimmune diabetes among children with type 1 diabetes and multiple autoimmune diseases: is it worth doing?.J Pediatr Endocrinol Metab. 2019 Oct 25;32(10):1147-1153. doi: 10.1515/jpem-2019-0261.
193 Expression of calcium release-activated and voltage-gated calcium channels genes in peripheral blood mononuclear cells is altered in pregnancy and in type 1 diabetes.PLoS One. 2018 Dec 13;13(12):e0208981. doi: 10.1371/journal.pone.0208981. eCollection 2018.
194 A cross-sectional study: serum CCL3/MIP-1 levels may reflect lumbar intervertebral disk degeneration in Han Chinese people.J Pain Res. 2018 Mar 5;11:497-503. doi: 10.2147/JPR.S152349. eCollection 2018.
195 Pulmonary Vein Ganglia Are Remodeled in the Diabetic Heart.J Am Heart Assoc. 2018 Dec 4;7(23):e008919. doi: 10.1161/JAHA.118.008919.
196 Controlled release of monoclonal antibodies from poly-l-lysine-coated alginate spheres within a scaffolded implant mitigates autoimmune responses to transplanted islets and limits systemic antibody toxicity.Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:390-398. doi: 10.1016/j.msec.2018.07.056. Epub 2018 Jul 25.
197 Long noncoding RNA FAF1 promotes intervertebral disc degeneration by targeting the Erk signaling pathway.Mol Med Rep. 2018 Feb;17(2):3158-3163. doi: 10.3892/mmr.2017.8237. Epub 2017 Dec 11.
198 Does meal-time insulin dosing based on fat-protein counting give positive results in postprandial glycaemic profile after a high protein-fat meal in adolescents with type 1 diabetes: a randomised controlled trial.J Hum Nutr Diet. 2020 Jun;33(3):396-403. doi: 10.1111/jhn.12711. Epub 2019 Oct 24.
199 Gastrin secretion in normal subjects and diabetes patients is inhibited by glucagon-like peptide 1: a role in the gastric side effects of GLP-1-derived drugs?.Scand J Gastroenterol. 2019 Dec;54(12):1448-1451. doi: 10.1080/00365521.2019.1690673. Epub 2019 Nov 14.
200 Down-regulation of insulin-like growth factor binding protein 5 is involved in intervertebral disc degeneration via the ERK signalling pathway.J Cell Mol Med. 2019 Sep;23(9):6368-6377. doi: 10.1111/jcmm.14525. Epub 2019 Jul 10.
201 Early Detection of Peripheral Blood Cell Signature in Children Developing -Cell Autoimmunity at a Young Age.Diabetes. 2019 Oct;68(10):2024-2034. doi: 10.2337/db19-0287. Epub 2019 Jul 16.
202 A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.J Immunol. 2019 Jun 15;202(12):3381-3393. doi: 10.4049/jimmunol.1801394. Epub 2019 May 10.
203 MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory -cell damage.PLoS One. 2018 Sep 27;13(9):e0203713. doi: 10.1371/journal.pone.0203713. eCollection 2018.
204 Phosphatidylserine expressing microvesicles in relation to microvascular complications in type 1 diabetes.Thromb Res. 2018 Dec;172:158-164. doi: 10.1016/j.thromres.2018.10.026. Epub 2018 Oct 26.
205 Nicotinamide Phosphoribosyltransferase Inhibitor APO866 Prevents IL-1-Induced Human Nucleus Pulposus Cell Degeneration via Autophagy.Cell Physiol Biochem. 2018;49(6):2463-2482. doi: 10.1159/000493843. Epub 2018 Sep 27.
206 Abnormalities in proinsulin processing in islets from individuals with longstanding T1D.Transl Res. 2019 Nov;213:90-99. doi: 10.1016/j.trsl.2019.08.001. Epub 2019 Aug 9.
207 Neurophysiological Evidence for a Compensatory Activity during a Simple Oddball Task in Adolescents with Type 1 Diabetes Mellitus.J Diabetes Res. 2018 Jul 8;2018:8105407. doi: 10.1155/2018/8105407. eCollection 2018.
208 Resveratrol attenuates testicular apoptosis in type 1 diabetic mice: Role of Akt-mediated Nrf2 activation and p62-dependent Keap1 degradation.Redox Biol. 2018 Apr;14:609-617. doi: 10.1016/j.redox.2017.11.007. Epub 2017 Nov 8.
209 Characterization of host defense molecules in the human pancreas.Islets. 2019;11(4):89-101. doi: 10.1080/19382014.2019.1585165. Epub 2019 Jun 26.
210 Sirt6 overexpression suppresses senescence and apoptosis of nucleus pulposus cells by inducing autophagy in a model of intervertebral disc degeneration.Cell Death Dis. 2018 Jan 19;9(2):56. doi: 10.1038/s41419-017-0085-5.
211 Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D).J Immunol Res. 2019 Aug 1;2019:1780567. doi: 10.1155/2019/1780567. eCollection 2019.
212 Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin.J Biol Chem. 2004 Feb 20;279(8):6261-70. doi: 10.1074/jbc.M312062200. Epub 2003 Nov 24.
213 Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes.Cardiovasc Diabetol. 2018 Apr 25;17(1):61. doi: 10.1186/s12933-018-0705-0.
214 Lrmp and Bcat1 are candidates for the type I diabetes susceptibility locus Idd6.Autoimmunity. 2003 Jun;36(4):241-6. doi: 10.1080/0891693031000141068.
215 Identification of a novel type 1 diabetes susceptibility gene, T-bet.Hum Genet. 2004 Aug;115(3):177-84. doi: 10.1007/s00439-004-1146-2. Epub 2004 Jul 6.
216 UBASH3A Regulates the Synthesis and Dynamics of TCR-CD3 Complexes.J Immunol. 2019 Dec 1;203(11):2827-2836. doi: 10.4049/jimmunol.1801338. Epub 2019 Oct 28.
217 Risk of diabetic nephropathy in type 1 diabetes is associated with functional polymorphisms in RANTES receptor gene (CCR5): a sex-specific effect.Diabetes. 2005 Nov;54(11):3331-5. doi: 10.2337/diabetes.54.11.3331.
218 Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes.J Immunol. 1998 Sep 1;161(5):2629-35.
219 Normal C3b receptor (CR1) genomic polymorphism in patients with insulin-dependent diabetes mellitus (IDDM): is the low erythrocyte CR1 expression an acquired phenomenon?.Clin Exp Immunol. 1992 Jul;89(1):18-21. doi: 10.1111/j.1365-2249.1992.tb06870.x.
220 Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases.Nat Med. 2015 Sep;21(9):1018-27. doi: 10.1038/nm.3933. Epub 2015 Aug 24.
221 The involvement of regulated in development and DNA damage response 1 (REDD1) in the pathogenesis of intervertebral disc degeneration.Exp Cell Res. 2018 Nov 15;372(2):188-197. doi: 10.1016/j.yexcr.2018.10.001. Epub 2018 Oct 9.
222 Enhancement of soluble CD23 serum levels and cell-surface CD23-expression in subjects at increased risk of type 1 diabetes mellitus and in diabetic patients.Diabet Med. 1998 Apr;15(4):320-6. doi: 10.1002/(SICI)1096-9136(199804)15:4<320::AID-DIA563>3.0.CO;2-I.
223 Placental leptin in normal, diabetic and fetal growth-retarded pregnancies.Mol Hum Reprod. 2000 Aug;6(8):763-9. doi: 10.1093/molehr/6.8.763.
224 The TAF5L gene on chromosome 1q42 is associated with type 1 diabetes in Russian affected patients.Autoimmunity. 2005 Jun;38(4):283-93. doi: 10.1080/08916930500128594.
225 Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years.Diabetes. 2004 Nov;53(11):2998-3001. doi: 10.2337/diabetes.53.11.2998.
226 KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.Diabetes. 2003 Oct;52(10):2639-42. doi: 10.2337/diabetes.52.10.2639.
227 The immunoglobulin heavy-chain variable region in insulin-dependent diabetes mellitus: affected-sib-pair analysis and association studies.Am J Hum Genet. 1996 Aug;59(2):462-70.
228 Clinical Characteristics and Sequelae of Severe Hypertriglyceridemia in Pediatrics.Endocr Pract. 2018 Sep;24(9):789-795. doi: 10.4158/EP-2018-0106. Epub 2018 Aug 7.
229 Insulin-dependent diabetes--associated HLA-D region encoded determinants.Hum Immunol. 1985 Feb;12(2):59-64. doi: 10.1016/0198-8859(85)90343-x.
230 Potential of stem cell-derived exosomes to regenerate islets through Pdx-1 dependent mechanism in a rat model of type 1 diabetes.J Cell Physiol. 2019 Nov;234(11):20310-20321. doi: 10.1002/jcp.28631. Epub 2019 Apr 17.
231 MHC class I chain-related gene alleles 5 and 5.1 are transmitted more frequently to type 1 diabetes offspring in HBDI families.Ann N Y Acad Sci. 2002 Apr;958:309-11. doi: 10.1111/j.1749-6632.2002.tb02993.x.
232 Diabetes affects similarly the catalytic subunit and putative glucose-6-phosphate translocase of glucose-6-phosphatase.J Biol Chem. 1999 Nov 26;274(48):33866-8. doi: 10.1074/jbc.274.48.33866.
233 PVU II polymorphism of LST-1 (leucocyte specific transcript-1) in type I diabetes mellitus, Graves' disease and healthy controls.Eur J Immunogenet. 1995 Jun;22(3):277-82. doi: 10.1111/j.1744-313x.1995.tb00242.x.
234 Unravelled facets of milk derived opioid peptides: a focus on gut physiology, fractures and obesity.Int J Food Sci Nutr. 2020 Feb;71(1):36-49. doi: 10.1080/09637486.2019.1614540. Epub 2019 Jun 3.
235 Circulating TNF receptors and risk of renal disease progression, cardiovascular disease events and mortality in patients with diabetes: a systematic review and meta-analysis.Endocrine. 2020 Apr;68(1):32-43. doi: 10.1007/s12020-019-02153-y. Epub 2019 Dec 7.
236 Relationship of large multifunctional proteasome 7 gene polymorphism with susceptibility to type 1 diabetes mellitus and DR3 gene.Chin Med J (Engl). 2001 Dec;114(12):1263-6.
237 Mutations in the ABCC8 gene can cause autoantibody-negative insulin-dependent diabetes.Diabetes Metab. 2009 Jun;35(3):233-5. doi: 10.1016/j.diabet.2009.01.003. Epub 2009 Apr 1.
238 HtrA1 upregulates the expression of ADAMTS-5 in HNPCs via the ERK/NF-B/JNK signaling pathway.Am J Transl Res. 2019 Aug 15;11(8):5114-5121. eCollection 2019.
239 A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.Nature. 2007 Aug 2;448(7153):591-4. doi: 10.1038/nature06010. Epub 2007 Jul 15.
240 A systematic meta-analysis of genetic association studies for diabetic retinopathy.Diabetes. 2009 Sep;58(9):2137-47. doi: 10.2337/db09-0059. Epub 2009 Jul 8.
241 Inhibition of 12/15-Lipoxygenase Protects Against -Cell Oxidative Stress and Glycemic Deterioration in Mouse Models of Type 1 Diabetes.Diabetes. 2017 Nov;66(11):2875-2887. doi: 10.2337/db17-0215. Epub 2017 Aug 25.
242 Publisher Correction: Predictors of chronic kidney disease in type 1 diabetes: a longitudinal study from the AMD Annals initiative.Sci Rep. 2018 Apr 12;8(1):5999. doi: 10.1038/s41598-018-23163-2.
243 Enhancement of Adiponectin Ameliorates Nonalcoholic Fatty Liver Disease via Inhibition of FoxO1 in Type I Diabetic Rats.J Diabetes Res. 2018 Aug 16;2018:6254340. doi: 10.1155/2018/6254340. eCollection 2018.
244 AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.Endocr Pract. 2018 Mar;24(3):302-308. doi: 10.4158/PS-2017-0155.
245 Iddm30 controls pancreatic expression of Ccl11 (Eotaxin) and the Th1/Th2 balance within the insulitic lesions.J Immunol. 2014 Apr 15;192(8):3645-53. doi: 10.4049/jimmunol.1302383. Epub 2014 Mar 19.
246 Plasma immunological markers in pregnancy and cord blood: Apossible link between macrophage chemo-attractants and risk of childhood type 1 diabetes.Am J Reprod Immunol. 2018 Mar;79(3). doi: 10.1111/aji.12802. Epub 2017 Dec 20.
247 Soluble CD163 correlates with lipid metabolic adaptations in type 1 diabetes patients during ketoacidosis.J Diabetes Investig. 2019 Jan;10(1):67-72. doi: 10.1111/jdi.12869. Epub 2018 Jun 30.
248 CD19+IgM+ cells demonstrate enhanced therapeutic efficacy in type 1 diabetes mellitus.JCI Insight. 2018 Dec 6;3(23):e99860. doi: 10.1172/jci.insight.99860.
249 Phenotypic alterations in pancreatic lymph node stromal cells from human donors with type 1 diabetes and NOD mice.Diabetologia. 2019 Nov;62(11):2040-2051. doi: 10.1007/s00125-019-04984-w. Epub 2019 Sep 5.
250 A Novel Approach of Identifying Immunodominant Self and Viral Antigen Cross-Reactive T Cells and Defining the Epitopes They Recognize.Front Immunol. 2018 Dec 3;9:2811. doi: 10.3389/fimmu.2018.02811. eCollection 2018.
251 Type 1 diabetes impairs the mobilisation of highly-differentiated CD8+T cells during a single bout of acute exercise.Exerc Immunol Rev. 2019;25:64-82.
252 Proinsulin peptide promotes autoimmune diabetes in a novel HLA-DR3-DQ2-transgenic murine model of spontaneous disease.Diabetologia. 2019 Dec;62(12):2252-2261. doi: 10.1007/s00125-019-04994-8. Epub 2019 Oct 14.
253 Differences in B7 and CD28 family gene expression in the peripheral blood between newly diagnosed young-onset and adult-onset type 1 diabetes patients.Mol Cell Endocrinol. 2015 Sep 5;412:265-71. doi: 10.1016/j.mce.2015.05.012. Epub 2015 May 14.
254 Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.Diabetologia. 2004 Apr;47(4):686-94. doi: 10.1007/s00125-004-1372-0.
255 Pancreas size and exocrine function is decreased in young children with recent-onset Type 1 diabetes.Diabet Med. 2020 Aug;37(8):1340-1343. doi: 10.1111/dme.13987. Epub 2019 Jun 17.
256 Characterization of two deletions of the CTRC locus.Mol Genet Metab. 2013 Jul;109(3):296-300. doi: 10.1016/j.ymgme.2013.04.022. Epub 2013 May 10.
257 Comparison of cerebral and cutaneous microvascular dysfunction with the development of type 1 diabetes.Theranostics. 2019 Aug 12;9(20):5854-5868. doi: 10.7150/thno.33738. eCollection 2019.
258 Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers.Nat Genet. 2015 Apr;47(4):381-6. doi: 10.1038/ng.3245. Epub 2015 Mar 9.
259 Association between Neonatal Whole Blood Iron Content and Cytokines, Adipokines, and Other Immune Response Proteins.Nutrients. 2019 Mar 4;11(3):543. doi: 10.3390/nu11030543.
260 Inflammatory Serine Proteases Play a Critical Role in the Early Pathogenesis of Diabetic Cardiomyopathy.Cell Physiol Biochem. 2019;53(6):982-998. doi: 10.33594/000000190.
261 FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children.Front Immunol. 2019 Jan 22;10:19. doi: 10.3389/fimmu.2019.00019. eCollection 2019.
262 Genome wide identification of new genes and pathways in patients with both autoimmune thyroiditis and type 1 diabetes.J Autoimmun. 2015 Jun;60:32-9. doi: 10.1016/j.jaut.2015.03.006. Epub 2015 Apr 27.
263 An update on the role of RANKL-RANK/osteoprotegerin and WNT--catenin signaling pathways in pediatric diseases.World J Pediatr. 2019 Feb;15(1):4-11. doi: 10.1007/s12519-018-0198-7. Epub 2018 Oct 20.
264 The role and interaction of imprinted genes in human fetal growth.Philos Trans R Soc Lond B Biol Sci. 2015 Mar 5;370(1663):20140074. doi: 10.1098/rstb.2014.0074.
265 Psychometric testing of the Norwegian Diabetes Health Profile (DHP-18) in patients with type 1 diabetes.BMJ Open Diabetes Res Care. 2018 Dec 6;6(1):e000541. doi: 10.1136/bmjdrc-2018-000541. eCollection 2018.
266 Incretin-based therapies for patients with type 1 diabetes: a meta-analysis.Endocr Connect. 2019 Mar;8(3):277-288. doi: 10.1530/EC-18-0546.
267 World's smallest combined en bloc liver-pancreas transplantation.Pediatr Transplant. 2018 Feb;22(1):10.1111/petr.13082. doi: 10.1111/petr.13082. Epub 2017 Nov 15.
268 miR-486-5p Inhibits Inflammatory Response, Matrix Degradation and Apoptosis of Nucleus Pulposus Cells through Directly Targeting FOXO1 in Intervertebral Disc Degeneration.Cell Physiol Biochem. 2019;52(1):109-118. doi: 10.33594/000000008. Epub 2019 Feb 18.
269 Increased galanin expression in the celiac ganglion of BB diabetic rats.Neuropeptides. 2006 Feb;40(1):1-10. doi: 10.1016/j.npep.2005.08.005.
270 Identification of Novel T1D Risk Loci and Their Association With Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide Association Study.Diabetes Care. 2019 Aug;42(8):1414-1421. doi: 10.2337/dc18-2023. Epub 2019 May 31.
271 Effect of a glucagon receptor antibody (REMD-477) in type 1 diabetes: A randomized controlled trial. Diabetes Obes Metab. 2018 May;20(5):1302-1305.
272 A decision algorithm to identify patients with high probability of monogenic diabetes due to HNF1A mutations.Endocrine. 2019 Apr;64(1):75-81. doi: 10.1007/s12020-019-01863-7. Epub 2019 Feb 18.
273 Pancreatic ductal cell antigens are important in the development of invasive insulitis in Non-Obese Diabetic mice.J Neuroimmunol. 2019 Feb 15;327:1-9. doi: 10.1016/j.jneuroim.2019.01.001. Epub 2019 Jan 18.
274 Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.Nat Immunol. 2017 Dec;18(12):1321-1331. doi: 10.1038/ni.3854. Epub 2017 Oct 9.
275 Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes.J Biol Chem. 2017 Oct 27;292(43):17598-17608. doi: 10.1074/jbc.M117.804328. Epub 2017 Aug 31.
276 Association of HLA-G 3' untranslated region variants with type 1 diabetes mellitus.Hum Immunol. 2016 Apr;77(4):358-64. doi: 10.1016/j.humimm.2016.02.001. Epub 2016 Feb 13.
277 Frequency and Characteristics of MODY 1 (HNF4A Mutation) and MODY 5 (HNF1B Mutation): Analysis From the DPV Database.J Clin Endocrinol Metab. 2019 Mar 1;104(3):845-855. doi: 10.1210/jc.2018-01696.
278 The haptoglobin 2-2 genotype is associated with cardiac autonomic neuropathy in type 1 diabetes: the RETRO HDLc study.Acta Diabetol. 2020 Mar;57(3):271-278. doi: 10.1007/s00592-019-01422-6. Epub 2019 Sep 16.
279 Loss of intra-islet heparan sulfate is a highly sensitive marker of type 1 diabetes progression in humans.PLoS One. 2018 Feb 7;13(2):e0191360. doi: 10.1371/journal.pone.0191360. eCollection 2018.
280 Exaggerated adrenarche and altered cortisol metabolism in Type 1 diabetic children.Steroids. 2006 Jul;71(7):591-8. doi: 10.1016/j.steroids.2006.02.005. Epub 2006 Apr 17.
281 Analysis of serum Hsp90 as a potential biomarker of cell autoimmunity in type 1 diabetes.PLoS One. 2019 Jan 10;14(1):e0208456. doi: 10.1371/journal.pone.0208456. eCollection 2019.
282 Deficiency of immunoregulatory indoleamine 2,3-dioxygenase 1in juvenile diabetes.JCI Insight. 2018 Mar 22;3(6):e96244. doi: 10.1172/jci.insight.96244.
283 Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN- Production via Suppressing JAK-STAT Pathway.Endocr Metab Immune Disord Drug Targets. 2019;19(5):656-664. doi: 10.2174/1871530319666190301115654.
284 Effect of Hyperbaric Oxygen Therapy on Fatty Acid Composition and Insulin-like Growth Factor Binding Protein 1 in Adult Type 1 Diabetes Mellitus Patients: A Pilot Study.Can J Diabetes. 2020 Feb;44(1):22-29. doi: 10.1016/j.jcjd.2019.04.018. Epub 2019 May 8.
285 Growth hormone and insulin-like growth factor-I axis in type 1 diabetes.Growth Horm IGF Res. 2018 Feb;38:49-52. doi: 10.1016/j.ghir.2017.12.005. Epub 2017 Dec 13.
286 The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes.Diabetes Care. 2013 Sep;36(9):2794-802. doi: 10.2337/dc12-1986. Epub 2013 May 1.
287 Trans-presentation of interleukin-15 by interleukin-15 receptor alpha is dispensable for the pathogenesis of autoimmune type 1 diabetes.Cell Mol Immunol. 2017 Jul;14(7):590-596. doi: 10.1038/cmi.2015.102. Epub 2016 Feb 8.
288 IL-17 and limits of success.Cell Immunol. 2019 May;339:33-40. doi: 10.1016/j.cellimm.2018.09.001. Epub 2018 Sep 17.
289 Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive children.Diabetologia. 2013 Jul;56(7):1615-22. doi: 10.1007/s00125-013-2896-y. Epub 2013 Mar 29.
290 Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.Cell Mol Life Sci. 2020 Jan;77(1):179-194. doi: 10.1007/s00018-019-03168-4. Epub 2019 Jun 6.
291 IL23R (Interleukin 23 Receptor) Variants Protective against Inflammatory Bowel Diseases (IBD) Display Loss of Function due to Impaired Protein Stability and Intracellular Trafficking.J Biol Chem. 2016 Apr 15;291(16):8673-85. doi: 10.1074/jbc.M116.715870. Epub 2016 Feb 17.
292 CD122 blockade restores immunological tolerance in autoimmune type 1 diabetes via multiple mechanisms.JCI Insight. 2018 Jan 25;3(2):e96600. doi: 10.1172/jci.insight.96600. eCollection 2018 Jan 25.
293 Combining anti-IL-7R antibodies with autoantigen-specific immunotherapy enhances non-specific cytokine production but fails to prevent Type 1 Diabetes.PLoS One. 2019 Mar 25;14(3):e0214379. doi: 10.1371/journal.pone.0214379. eCollection 2019.
294 Case report: type 1 diabetes in monozygotic quadruplets.Eur J Hum Genet. 2012 Apr;20(4):457-62. doi: 10.1038/ejhg.2011.212. Epub 2011 Nov 23.
295 Leukotriene Involvement in the Insulin Receptor Pathway and Macrophage Profiles in Muscles from Type 1 Diabetic Mice.Mediators Inflamm. 2019 Jan 27;2019:4596127. doi: 10.1155/2019/4596127. eCollection 2019.
296 Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.Hum Immunol. 2010 Aug;71(8):799-803. doi: 10.1016/j.humimm.2010.05.014. Epub 2010 May 16.
297 UCP1-independent glucose-lowering effect of leptin in type 1 diabetes: only in conditions of hypoleptinemia.Am J Physiol Endocrinol Metab. 2020 Jan 1;318(1):E72-E86. doi: 10.1152/ajpendo.00253.2019. Epub 2019 Nov 19.
298 Metabolic control, ApoE genotypes, and dyslipidemia in children, adolescents and young adults with type 1 diabetes.Atherosclerosis. 2018 Jun;273:53-58. doi: 10.1016/j.atherosclerosis.2018.04.013. Epub 2018 Apr 12.
299 Leukotriene-B4 modulates macrophage metabolism and fat loss in type 1 diabetic mice.J Leukoc Biol. 2019 Sep;106(3):665-675. doi: 10.1002/JLB.MA1218-477RR. Epub 2019 Jun 26.
300 A genome-wide association study suggests that MAPK14 is associated with diabetic foot ulcers.Br J Dermatol. 2017 Dec;177(6):1664-1670. doi: 10.1111/bjd.15787. Epub 2017 Nov 27.
301 Downregulation of microRNA-193a-3p is involved in invertebral disc degeneration by targeting MMP14.J Mol Med (Berl). 2016 Apr;94(4):457-68. doi: 10.1007/s00109-015-1371-2. Epub 2015 Dec 1.
302 Chronic resveratrol treatment restores vascular responsiveness of cerebral arterioles in type 1 diabetic rats.Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H696-703. doi: 10.1152/ajpheart.00312.2011. Epub 2011 Jun 10.
303 Tetrahydrobiopterin rescues impaired responses of cerebral resistance arterioles during type 1 diabetes.Diab Vasc Dis Res. 2017 Jan;14(1):33-39. doi: 10.1177/1479164116675490. Epub 2016 Nov 14.
304 Impact of type 1 diabetes mellitus and sitagliptin treatment on the neuropeptide Y system of rat retina.Clin Exp Ophthalmol. 2018 Sep;46(7):783-795. doi: 10.1111/ceo.13176. Epub 2018 Mar 5.
305 Circulating CXCR5(-)PD-1(hi) peripheral T helper cells are associated with progression to type 1 diabetes.Diabetologia. 2019 Sep;62(9):1681-1688. doi: 10.1007/s00125-019-4936-8. Epub 2019 Jul 3.
306 Pharmacokinetic and pharmacodynamic bioequivalence of proposed biosimilar MYL-1501D with US and European insulin glargine formulations in patients with type 1 diabetes mellitus.Diabetes Obes Metab. 2020 Apr;22(4):521-529. doi: 10.1111/dom.13919. Epub 2019 Dec 15.
307 Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases.J Immunol. 2011 Sep 1;187(5):2302-9. doi: 10.4049/jimmunol.1101003. Epub 2011 Jul 29.
308 New Locus for Skin Intrinsic Fluorescence in Type 1 Diabetes Also Associated With Blood and Skin Glycated Proteins.Diabetes. 2016 Jul;65(7):2060-71. doi: 10.2337/db15-1484. Epub 2016 Apr 12.
309 Integrative Bioinformatics Analysis Reveals Potential Gene Biomarkers and Analysis of Function in Human Degenerative Disc Annulus Fibrosus Cells.Biomed Res Int. 2019 Feb 21;2019:9890279. doi: 10.1155/2019/9890279. eCollection 2019.
310 Assessment of biomarkers of inflammation and premature atherosclerosis in adolescents with type-1 diabetes mellitus.J Pediatr Endocrinol Metab. 2019 Feb 25;32(2):109-113. doi: 10.1515/jpem-2018-0192.
311 Changes in the expression of many Ets family transcription factors and of potential target genes in normal mammary tissue and tumors.J Biol Chem. 2004 Mar 19;279(12):11281-92. doi: 10.1074/jbc.M311887200. Epub 2003 Dec 8.
312 A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia()) in the Treatment of Recent-Onset Type 1 Diabetes.Int J Mol Sci. 2019 Nov 29;20(23):6032. doi: 10.3390/ijms20236032.
313 Combined SIRT3 and SIRT5 deletion is associated with inner retinal dysfunction in a mouse model of type 1 diabetes.Sci Rep. 2019 Mar 7;9(1):3799. doi: 10.1038/s41598-019-40177-6.
314 Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [(18)F]FP-DTBZ in Healthy Subjects and Patients with Type 1 Diabetes.Mol Imaging Biol. 2018 Oct;20(5):835-845. doi: 10.1007/s11307-018-1170-6.
315 Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials.BMJ. 2019 Apr 9;365:l1328. doi: 10.1136/bmj.l1328.
316 Efficacy and Safety of SGLT2 Inhibitors in Type 1 Diabetes After the Introduction of an Off-Label Use Protocol for Clinical Practice.Diabetes Technol Ther. 2020 Mar;22(3):208-215. doi: 10.1089/dia.2019.0316. Epub 2019 Oct 23.
317 Screening of differentially expressed genes in male idiopathic osteoporosis via RNA sequencing.Mol Med Rep. 2018 Jul;18(1):67-76. doi: 10.3892/mmr.2018.8985. Epub 2018 May 7.
318 Functional SOCS1 polymorphisms are associated with variation in obesity in whites.Diabetes Obes Metab. 2009 Mar;11(3):196-203. doi: 10.1111/j.1463-1326.2008.00900.x.
319 Type 1 Diabetes in STAT Protein Family Mutations: Regulating the Th17/Treg Equilibrium and Beyond.Diabetes. 2019 Feb;68(2):258-265. doi: 10.2337/db18-0627.
320 The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes.BMC Med Genet. 2007 Nov 28;8:71. doi: 10.1186/1471-2350-8-71.
321 Association of common type 1 and type 2 diabetes gene variants with latent autoimmune diabetes in adults: A meta-analysis.J Diabetes. 2019 Jun;11(6):484-496. doi: 10.1111/1753-0407.12879. Epub 2018 Dec 12.
322 A20 Inhibits -Cell Apoptosis by Multiple Mechanisms and Predicts Residual -Cell Function in Type 1 Diabetes.Mol Endocrinol. 2016 Jan;30(1):48-61. doi: 10.1210/me.2015-1176. Epub 2015 Dec 10.
323 OPG/RANK/RANKL signaling axis in patients with type I diabetes: Associations with parathormone and vitamin D.Ital J Pediatr. 2019 Dec 10;45(1):161. doi: 10.1186/s13052-019-0748-1.
324 Combined congenic mapping and nuclease-based gene targeting for studying allele-specific effects of Tnfrsf9 within the Idd9.3 autoimmune diabetes locus.Sci Rep. 2019 Mar 13;9(1):4316. doi: 10.1038/s41598-019-40898-8.
325 Meta-Analysis of the Association Between FAS Ligand and TRAIL Genetic Polymorphisms and Intervertebral Disc Degeneration Susceptibility in Chinese Han population.Spine (Phila Pa 1976). 2018 Nov 15;43(22):1602-1608. doi: 10.1097/BRS.0000000000002673.
326 Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients.EBioMedicine. 2019 Apr;42:76-85. doi: 10.1016/j.ebiom.2019.03.063. Epub 2019 Apr 3.
327 The characteristics and pivotal roles of triggering receptor expressed on myeloid cells-1 in autoimmune diseases.Autoimmun Rev. 2019 Jan;18(1):25-35. doi: 10.1016/j.autrev.2018.07.008. Epub 2018 Nov 5.
328 TRPC channels: Regulation, dysregulation and contributions to chronic kidney disease.Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1041-1066. doi: 10.1016/j.bbadis.2019.04.001. Epub 2019 Apr 4.
329 Endocannabinoid system acts as a regulator of immune homeostasis in the gut.Proc Natl Acad Sci U S A. 2017 May 9;114(19):5005-5010. doi: 10.1073/pnas.1612177114. Epub 2017 Apr 24.
330 Glucose-responsive complex micelles for self-regulated delivery of insulin with effective protection of insulin and enhanced hypoglycemic activity in vivo.Colloids Surf B Biointerfaces. 2019 Aug 1;180:376-383. doi: 10.1016/j.colsurfb.2019.05.003. Epub 2019 May 6.
331 Hypoglycemia: Role of Hypothalamic Glucose-Inhibited (GI) Neurons in Detection and Correction.Front Physiol. 2018 Mar 9;9:192. doi: 10.3389/fphys.2018.00192. eCollection 2018.
332 -866G/A and Ins/Del polymorphisms in the UCP2 gene and diabetic kidney disease: case-control study and meta-analysis.Genet Mol Biol. 2020 Mar 27;43(2):e20180374. doi: 10.1590/1678-4685-GMB-2018-0374. eCollection 2020.
333 IDDM17: polymorphisms in the AMACO gene are associated with dominant protection against type 1A diabetes in a Bedouin Arab family.Ann N Y Acad Sci. 2004 Dec;1037:145-9. doi: 10.1196/annals.1337.024.
334 A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci.PLoS Genet. 2011 Sep;7(9):e1002293. doi: 10.1371/journal.pgen.1002293. Epub 2011 Sep 29.
335 Elevated high-density lipoprotein in adolescents with Type 1 diabetes is associated with endothelial dysfunction in the presence of systemic inflammation.Eur Heart J. 2019 Nov 14;40(43):3559-3566. doi: 10.1093/eurheartj/ehz114.
336 MicroRNA-143-5p targeting eEF2 gene mediates intervertebral disc degeneration through the AMPK signaling pathway.Arthritis Res Ther. 2019 Apr 15;21(1):97. doi: 10.1186/s13075-019-1863-5.
337 Bone Morphogenetic Protein-6 Attenuates Type 1 Diabetes Mellitus-Associated Bone Loss.Stem Cells Transl Med. 2019 Jun;8(6):522-534. doi: 10.1002/sctm.18-0150. Epub 2019 Feb 19.
338 Structural basis for ligand modulation of the CCR2 conformational landscape.Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8131-8136. doi: 10.1073/pnas.1814131116. Epub 2019 Apr 11.
339 Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.Diabetes Care. 2019 Dec;42(12):2290-2297. doi: 10.2337/dc19-1062. Epub 2019 Oct 3.
340 Increase in Peripheral Blood Intermediate Monocytes is Associated with the Development of Recent-Onset Type 1 Diabetes Mellitus in Children.Int J Biol Sci. 2017 Feb 5;13(2):209-218. doi: 10.7150/ijbs.15659. eCollection 2017.
341 Poor Glycemic Control Is Associated With Impaired Bone Accrual in the Year Following a Diagnosis of Type 1 Diabetes.J Clin Endocrinol Metab. 2019 Oct 1;104(10):4511-4520. doi: 10.1210/jc.2019-00035.
342 eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 Diabetes.Sci Rep. 2019 Feb 7;9(1):1533. doi: 10.1038/s41598-018-38341-5.
343 Altered expression of CD39 on memory regulatory T cells in type 1 diabetes patients.J Diabetes. 2019 Jun;11(6):440-448. doi: 10.1111/1753-0407.12870. Epub 2018 Nov 11.
344 Bone Marrow-Derived Cells Restore Functional Integrity of the Gut Epithelial and Vascular Barriers in a Model of Diabetes and ACE2 Deficiency.Circ Res. 2019 Nov 8;125(11):969-988. doi: 10.1161/CIRCRESAHA.119.315743. Epub 2019 Oct 15.
345 Upregulated miR-154 promotes ECM degradation in intervertebral disc degeneration.J Cell Biochem. 2019 Jul;120(7):11900-11907. doi: 10.1002/jcb.28471. Epub 2019 Mar 1.
346 Overexpression of growth and differentiation factor-5 inhibits inflammatory factors released by intervertebral disc cells.Exp Ther Med. 2018 Apr;15(4):3603-3608. doi: 10.3892/etm.2018.5867. Epub 2018 Feb 14.
347 Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study.Cardiovasc Diabetol. 2019 Mar 28;18(1):43. doi: 10.1186/s12933-019-0846-9.
348 Maternal and Newborn Vitamin D-Binding Protein, Vitamin D Levels, Vitamin D Receptor Genotype, and Childhood Type 1 Diabetes.Diabetes Care. 2019 Apr;42(4):553-559. doi: 10.2337/dc18-2176. Epub 2019 Jan 28.
349 A rationally designed peptide IA-2-P2 against type 1 diabetes in streptozotocin-induced diabetic mice.Diab Vasc Dis Res. 2017 May;14(3):184-190. doi: 10.1177/1479164116664189. Epub 2017 Mar 1.
350 Elevated histone H3 acetylation is associated with genes involved in T lymphocyte activation and glutamate decarboxylase antibody production in patients with type 1 diabetes.J Diabetes Investig. 2019 Jan;10(1):51-61. doi: 10.1111/jdi.12867. Epub 2018 Jun 26.
351 Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects.Hum Mol Genet. 2010 May 15;19(10):2059-67. doi: 10.1093/hmg/ddq078. Epub 2010 Feb 22.
352 Investigation of coordination and order in transcription regulation of innate and adaptive immunity genes in type 1 diabetes.BMC Med Genomics. 2017 Jan 31;10(1):7. doi: 10.1186/s12920-017-0243-8.
353 Dietary SCFAs, IL-22, and GFAP: The Three Musketeers in the Gut-Neuro-Immune Network in Type 1 Diabetes.Front Immunol. 2019 Oct 29;10:2429. doi: 10.3389/fimmu.2019.02429. eCollection 2019.
354 Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following in vitro stimulation with -cell autoantigens.Indian J Med Res. 2017 Jun;145(6):767-776. doi: 10.4103/ijmr.IJMR_1563_15.
355 Genome-Wide Association Study Confirming a Strong Effect of HLA and Identifying Variants in CSAD/lnc-ITGB7-1 on Chromosome 12q13.13 Associated With Susceptibility to Fulminant Type 1 Diabetes.Diabetes. 2019 Mar;68(3):665-675. doi: 10.2337/db18-0314. Epub 2018 Dec 14.
356 Targeted disruption of glycogen synthase kinase-3 in cardiomyocytes attenuates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice.PLoS One. 2019 Apr 12;14(4):e0215213. doi: 10.1371/journal.pone.0215213. eCollection 2019.
357 The relationships between markers of tubular injury and intrarenal haemodynamic function in adults with and without type 1 diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.Diabetes Obes Metab. 2019 Mar;21(3):575-583. doi: 10.1111/dom.13556. Epub 2018 Nov 11.
358 Poorly-Controlled Type 1 Diabetes Mellitus Impairs LH-LHCGR Signaling in the Ovaries and Decreases Female Fertility in Mice.Yonsei Med J. 2019 Jul;60(7):667-678. doi: 10.3349/ymj.2019.60.7.667.
359 Hypothalamic POMC or MC4R deficiency impairs counterregulatory responses to hypoglycemia in mice.Mol Metab. 2019 Feb;20:194-204. doi: 10.1016/j.molmet.2018.11.004. Epub 2018 Nov 20.
360 Elevated T cell levels in peripheral blood predict poor clinical response following rituximab treatment in new-onset type 1 diabetes.Genes Immun. 2019 Apr;20(4):293-307. doi: 10.1038/s41435-018-0032-1. Epub 2018 Jun 21.
361 Myostatin alters with exercise training in diabetic rats; possible interaction with glycosylated hemoglobin and inflammatory cytokines.Cytokine. 2019 Aug;120:99-106. doi: 10.1016/j.cyto.2019.04.012. Epub 2019 May 1.
362 Neutrophil Cytosolic Factor 1 in Dendritic Cells Promotes Autoreactive CD8(+) T Cell Activation via Cross-Presentation in Type 1 Diabetes.Front Immunol. 2019 May 1;10:952. doi: 10.3389/fimmu.2019.00952. eCollection 2019.
363 Human anti-NKp46 antibody for studies of NKp46-dependent NK cell function and its applications for type 1 diabetes and cancer research.Eur J Immunol. 2019 Feb;49(2):228-241. doi: 10.1002/eji.201847611. Epub 2018 Dec 17.
364 Polymorphisms in NLRP1 Gene Are Associated with Type 1 Diabetes.J Diabetes Res. 2019 Jul 14;2019:7405120. doi: 10.1155/2019/7405120. eCollection 2019.
365 NLRX1 does not play a role in diabetes nor the development of diabetic nephropathy induced by multiple low doses of streptozotocin.PLoS One. 2019 Mar 25;14(3):e0214437. doi: 10.1371/journal.pone.0214437. eCollection 2019.
366 Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.Atherosclerosis. 2019 Jan;280:14-20. doi: 10.1016/j.atherosclerosis.2018.11.020. Epub 2018 Nov 9.
367 Activation of the HIF1/PFKFB3 stress response pathway in beta cells in type 1 diabetes.Diabetologia. 2020 Jan;63(1):149-161. doi: 10.1007/s00125-019-05030-5. Epub 2019 Nov 13.
368 Evaluation of lipoprotein-associated phospholipase A2 as a marker for renal microvasculopathy in adolescents with Type 1 diabetes.Diabet Med. 2020 Jan;37(1):75-83. doi: 10.1111/dme.14086. Epub 2019 Aug 5.
369 Sigma 1 receptor mediated HMGB1 expression in spinal cord is involved in the development of diabetic neuropathic pain.Neurosci Lett. 2018 Mar 6;668:164-168. doi: 10.1016/j.neulet.2018.02.002. Epub 2018 Feb 5.
370 Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy.Diab Vasc Dis Res. 2020 Jan-Feb;17(1):1479164119878427. doi: 10.1177/1479164119878427. Epub 2019 Nov 14.
371 D-ribose is elevated in T1DM patients and can be involved in the onset of encephalopathy.Aging (Albany NY). 2019 Jul 15;11(14):4943-4969. doi: 10.18632/aging.102089.
372 TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells.J Autoimmun. 2018 Sep;93:57-65. doi: 10.1016/j.jaut.2018.06.003. Epub 2018 Jun 28.
373 Cytoplasmic ends of tetraspanin 7 harbour epitopes recognised by autoantibodies in type 1 diabetes.Diabetologia. 2019 May;62(5):805-810. doi: 10.1007/s00125-019-4832-2. Epub 2019 Feb 21.
374 Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes.Diabetologia. 2018 Feb;61(2):399-412. doi: 10.1007/s00125-017-4462-5. Epub 2017 Oct 7.
375 Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.BMC Med Genet. 2006 Jun 23;7:54. doi: 10.1186/1471-2350-7-54.
376 DNA methylation and mRNA expression of HLA-DQA1 alleles in type 1 diabetes mellitus.Immunology. 2016 Jun;148(2):150-9. doi: 10.1111/imm.12593. Epub 2016 Mar 7.
377 The impact of autoimmune thyroiditis on skin microcirculation in children with non-complicated type 1 diabetes mellitus.Microvasc Res. 2019 May;123:68-73. doi: 10.1016/j.mvr.2019.01.002. Epub 2019 Jan 3.
378 Taurine Transporter Gene Expression in Mononuclear Blood Cells of Type 1 Diabetes Patients.J Diabetes Res. 2016;2016:7313162. doi: 10.1155/2016/7313162. Epub 2016 Feb 3.
379 Polymorphisms at positions -22 and -348 in the promoter of the BAT1 gene affect transcription and the binding of nuclear factors.Hum Mol Genet. 2004 May 1;13(9):967-74. doi: 10.1093/hmg/ddh113. Epub 2004 Mar 17.
380 Building a bridge between clinical and basic research: the phenotypic elements of familial predisposition to type 1 diabetes.Curr Med Chem. 2007;14(5):555-67. doi: 10.2174/092986707780059689.
381 Akt2 (Protein Kinase B Beta) Stabilizes ATP7A, a Copper Transporter for Extracellular Superoxide Dismutase, in Vascular Smooth Muscle: Novel Mechanism to Limit Endothelial Dysfunction in Type 2 Diabetes Mellitus.Arterioscler Thromb Vasc Biol. 2018 Mar;38(3):529-541. doi: 10.1161/ATVBAHA.117.309819. Epub 2018 Jan 4.
382 Immense Insulin Intestinal Uptake and Lymphatic Transport Using Bile Acid Conjugated Partially Uncapped Liposome.Mol Pharm. 2018 Oct 1;15(10):4756-4763. doi: 10.1021/acs.molpharmaceut.8b00708. Epub 2018 Aug 29.
383 Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin.Diabetes. 2004 Aug;53(8):1979-86. doi: 10.2337/diabetes.53.8.1979.
384 No abnormalities of reg1 alpha and reg1 beta gene associated with diabetes mellitus.Diabetes Res Clin Pract. 2002 Feb;55(2):105-11. doi: 10.1016/s0168-8227(01)00321-7.
385 IA-2 antibody epitopes and isotypes during the prediabetic process in siblings of children with type 1 diabetes.J Autoimmun. 2004 Dec;23(4):361-70. doi: 10.1016/j.jaut.2004.09.005.
386 A novel 3' untranslated region mutation in the SLC29A3 gene associated with pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus syndrome.Pediatr Diabetes. 2019 Jun;20(4):474-481. doi: 10.1111/pedi.12839. Epub 2019 Apr 2.
387 Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study.Diabetologia. 2020 Feb;63(2):278-286. doi: 10.1007/s00125-019-05028-z. Epub 2019 Nov 14.
388 Glucose Metabolism Is Required for Platelet Hyperactivation in a Murine Model of Type 1 Diabetes.Diabetes. 2019 May;68(5):932-938. doi: 10.2337/db18-0981. Epub 2019 Feb 14.
389 Contribution of VDR polymorphisms to type 1 diabetes susceptibility: Systematic review of case-control studies and meta-analysis.J Steroid Biochem Mol Biol. 2014 Sep;143:240-9. doi: 10.1016/j.jsbmb.2014.03.011. Epub 2014 Apr 15.
390 Aerobic Endurance Training Does Not Protect Bone Against Poorly Controlled Type 1 Diabetes in Young Adult Rats.Calcif Tissue Int. 2017 Apr;100(4):374-381. doi: 10.1007/s00223-016-0227-2. Epub 2017 Jan 21.
391 Peroxisome proliferator-activated receptor-gamma coactivator-1alpha activation of CYP7A1 during food restriction and diabetes is still inhibited by small heterodimer partner.J Biol Chem. 2008 May 30;283(22):15089-96. doi: 10.1074/jbc.M710452200. Epub 2008 Apr 2.
392 Relationship between DDAH gene variants and serum ADMA level in individuals with type 1 diabetes.J Diabetes Complications. 2012 May-Jun;26(3):195-8. doi: 10.1016/j.jdiacomp.2012.03.022. Epub 2012 Apr 20.
393 ANKRD55 and DHCR7 are novel multiple sclerosis risk loci.Genes Immun. 2012 Apr;13(3):253-7. doi: 10.1038/gene.2011.81. Epub 2011 Dec 1.
394 Protection from type 1 diabetes by vitamin D receptor haplotypes.Ann N Y Acad Sci. 2006 Oct;1079:327-34. doi: 10.1196/annals.1375.050.
395 Metabolic profile and nitric oxide synthase expression of skeletal muscle fibers are altered in patients with type 1 diabetes.Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):606-13. doi: 10.1055/s-2008-1073126. Epub 2008 May 9.
396 Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes.Diabetologia. 2018 Dec;61(12):2580-2589. doi: 10.1007/s00125-018-4725-9. Epub 2018 Sep 18.
397 Allele-specific methylation of type 1 diabetes susceptibility genes.J Autoimmun. 2018 May;89:63-74. doi: 10.1016/j.jaut.2017.11.008. Epub 2017 Dec 8.
398 FUT2 non-secretor status is associated with Type 1 diabetes susceptibility in Japanese children.Diabet Med. 2017 Apr;34(4):586-589. doi: 10.1111/dme.13288. Epub 2016 Dec 15.
399 Vitamin D level and gene polymorphisms in Korean children with type 1 diabetes.Pediatr Diabetes. 2019 Sep;20(6):750-758. doi: 10.1111/pedi.12878. Epub 2019 Jul 2.
400 Allelic variations in genes belonging to glutathione system increase proliferative retinopathy risk in type 1 diabetes individuals.Gene. 2019 Jun 30;703:120-124. doi: 10.1016/j.gene.2019.04.015. Epub 2019 Apr 5.
401 Gene Polymorphisms of Glutathione S-Transferase T1/M1 in Egyptian Children and Adolescents with Type 1 Diabetes Mellitus.J Clin Res Pediatr Endocrinol. 2017 Jun 1;9(2):138-143. doi: 10.4274/jcrpe.3690. Epub 2016 Dec 2.
402 Comparison of the effect of a compact vs a conventional, long-term education program on metabolic control in children and adolescents with type 1 diabetes: A pilot, randomized clinical trial.Pediatr Diabetes. 2019 Sep;20(6):778-784. doi: 10.1111/pedi.12879. Epub 2019 Jun 30.
403 Effects of Cholecalciferol on Key Components of Vitamin D-Endo/Para/Autocrine System in Experimental Type 1 Diabetes.Int J Endocrinol. 2018 Feb 6;2018:2494016. doi: 10.1155/2018/2494016. eCollection 2018.
404 Clock genes alterations and endocrine disorders.Eur J Clin Invest. 2018 Jun;48(6):e12927. doi: 10.1111/eci.12927. Epub 2018 Apr 16.
405 Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1.Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):E715-24. doi: 10.1073/pnas.1111600109. Epub 2012 Jan 17.
406 A study of three polymorphic sites of the ADA gene in children with type 1 diabetes mellitus.J Pediatr Endocrinol Metab. 2010 Mar;23(3):283-90. doi: 10.1515/jpem.2010.23.3.283.
407 Multiple sclerosis association study with the TENR-IL2-IL21 region in a Spanish population.Tissue Antigens. 2009 Sep;74(3):244-7. doi: 10.1111/j.1399-0039.2009.01298.x. Epub 2009 Jun 11.
408 Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort.J Diabetes Complications. 2005 Jan-Feb;19(1):18-25. doi: 10.1016/j.jdiacomp.2004.04.005.
409 Investigation of Adducin 2 (beta) DNA polymorphisms in genetic predisposition to diabetic nephropathy in Type 1 diabetes.Diabet Med. 2008 Aug;25(8):1001-5. doi: 10.1111/j.1464-5491.2008.02511.x.
410 Therapeutic window of globular adiponectin against cerebral ischemia in diabetic mice: the role of dynamic alteration of adiponectin/adiponectin receptor expression.Sci Rep. 2015 Nov 27;5:17310. doi: 10.1038/srep17310.
411 Expression of adiponectin and its receptors in type 1 diabetes mellitus in human and mouse retinas.Mol Vis. 2013 Aug 4;19:1769-78. Print 2013.
412 Protective effect of FGF21 on type 1 diabetes-induced testicular apoptotic cell death probably via both mitochondrial- and endoplasmic reticulum stress-dependent pathways in the mouse model.Toxicol Lett. 2013 May 10;219(1):65-76. doi: 10.1016/j.toxlet.2013.02.022. Epub 2013 Mar 7.
413 A novel ALMS1 splice mutation in a non-obese juvenile-onset insulin-dependent syndromic diabetic patient.Eur J Hum Genet. 2014 Jan;22(1):140-3. doi: 10.1038/ejhg.2013.87. Epub 2013 May 8.
414 A regulatory role for -adrenergic receptors regarding the resolvin D1 (RvD1) pathway in the diabetic retina.PLoS One. 2017 Nov 2;12(11):e0185383. doi: 10.1371/journal.pone.0185383. eCollection 2017.
415 Metformin as add-on to intensive insulin therapy in type 1 diabetes mellitus.Diabetes Obes Metab. 2017 Oct;19(10):1463-1467. doi: 10.1111/dom.12948. Epub 2017 May 22.
416 ISA-2011B, a Phosphatidylinositol 4-Phosphate 5-Kinase Inhibitor, Impairs CD28-Dependent Costimulatory and Pro-inflammatory Signals in Human T Lymphocytes.Front Immunol. 2017 Apr 26;8:502. doi: 10.3389/fimmu.2017.00502. eCollection 2017.
417 Cutting Edge: Loss of T Cell RIAM Precludes Conjugate Formation with APC and Prevents Immune-Mediated Diabetes.J Immunol. 2017 May 1;198(9):3410-3415. doi: 10.4049/jimmunol.1601743. Epub 2017 Mar 27.
418 Genetic associations with diabetes: meta-analyses of 10 candidate polymorphisms.PLoS One. 2013 Jul 29;8(7):e70301. doi: 10.1371/journal.pone.0070301. Print 2013.
419 APPL1 prevents pancreatic beta cell death and inflammation by dampening NFB activation in a mouse model of type 1 diabetes.Diabetologia. 2017 Mar;60(3):464-474. doi: 10.1007/s00125-016-4185-z. Epub 2016 Dec 23.
420 microRNA?6 regulates the proliferation of nucleus pulposus cells by targeting ARID2/AKT signaling.Mol Med Rep. 2017 Nov;16(5):7553-7560. doi: 10.3892/mmr.2017.7560. Epub 2017 Sep 20.
421 IL-1 increases asporin expression via the NF-B p65 pathway in nucleus pulposus cells during intervertebral disc degeneration.Sci Rep. 2017 Jun 23;7(1):4112. doi: 10.1038/s41598-017-04384-3.
422 Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin.J Immunol. 2010 Jan 15;184(2):658-65. doi: 10.4049/jimmunol.0903414. Epub 2009 Dec 4.
423 Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31.Adv Healthc Mater. 2018 Sep;7(18):e1800341. doi: 10.1002/adhm.201800341. Epub 2018 Jul 26.
424 Hypomethylation within gene promoter regions and type 1 diabetes in discordant monozygotic twins.J Autoimmun. 2016 Apr;68:23-9. doi: 10.1016/j.jaut.2015.12.003. Epub 2016 Jan 9.
425 Association of BANK1 and cytokine gene polymorphisms with type 1 diabetes in Tunisia.Gene. 2014 Feb 25;536(2):296-301. doi: 10.1016/j.gene.2013.12.008. Epub 2013 Dec 14.
426 Transplantation of betacellulin-transduced islets improves glucose intolerance in diabetic mice.Exp Mol Med. 2014 May 30;46(5):e98. doi: 10.1038/emm.2014.24.
427 Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex.Genes Immun. 2009 Jun;10(4):323-33. doi: 10.1038/gene.2009.13. Epub 2009 Mar 19.
428 Analysis of loss-of-function variants and 20 risk factor phenotypes in 8,554 individuals identifies loci influencing chronic disease.Nat Genet. 2015 Jun;47(6):640-2. doi: 10.1038/ng.3270. Epub 2015 Apr 27.
429 CTRP9 Regulates Growth, Differentiation, and Apoptosis in Human Keratinocytes through TGF1-p38-Dependent Pathway.Mol Cells. 2017 Dec 31;40(12):906-915. doi: 10.14348/molcells.2017.0097. Epub 2017 Nov 16.
430 Role of genetic alterations in the NLRP3 and CARD8 genes in health and disease.Mediators Inflamm. 2015;2015:846782. doi: 10.1155/2015/846782. Epub 2015 Feb 18.
431 Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis.Ann Rheum Dis. 2008 Mar;67(3):409-13. doi: 10.1136/ard.2007.075028. Epub 2007 Jun 29.
432 Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes.Immunol Res. 2005;31(3):177-88. doi: 10.1385/IR:31:3:177.
433 IMPROVED HBA1C, TOTAL DAILY INSULIN DOSE, AND TREATMENT SATISFACTION WITH INSULIN PUMP THERAPY COMPARED TO MULTIPLE DAILY INSULIN INJECTIONS IN PATIENTS WITH TYPE 2 DIABETES IRRESPECTIVE OF BASELINE C-PEPTIDE LEVELS.Endocr Pract. 2018 May;24(5):446-452. doi: 10.4158/EP-2017-0234.
434 Chromosome 2q31.1 associates with ESRD in women with type 1 diabetes.J Am Soc Nephrol. 2013 Oct;24(10):1537-43. doi: 10.1681/ASN.2012111122. Epub 2013 Sep 12.
435 Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families.Genes Immun. 2009 Dec;10 Suppl 1(Suppl 1):S74-84. doi: 10.1038/gene.2009.96.
436 On the perils of poor editing: regulation of peptide loading by HLA-DQ and H2-A molecules associated with celiac disease and type 1 diabetes.Expert Rev Mol Med. 2012 Jul 6;14:e15. doi: 10.1017/erm.2012.9.
437 Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis.Arthritis Rheum. 2009 Mar;60(3):653-60. doi: 10.1002/art.24362.
438 Inflammatory microRNA-194 and -515 attenuate the biosynthesis of chondroitin sulfate during human intervertebral disc degeneration.Oncotarget. 2017 Jul 25;8(30):49303-49317. doi: 10.18632/oncotarget.17571.
439 Polymorphism E23K (rs5219) in the KCNJ11 gene in Euro-Brazilian subjects with type 1 and 2 diabetes.Genet Mol Res. 2017 Apr 5;16(2). doi: 10.4238/gmr16029543.
440 Impact of deprivation, ethnicity, and insulin pump therapy on developmental trajectories of diabetes control in COB type 1 diabetes.Pediatr Diabetes. 2017 Aug;18(5):384-391. doi: 10.1111/pedi.12407. Epub 2016 Aug 18.
441 Comparison between preprandial vs. postprandial insulin aspart in patients with type 1 diabetes on insulin pump and real-time continuous glucose monitoring.Diabetes Metab Res Rev. 2018 Sep;34(6):e3019. doi: 10.1002/dmrr.3019. Epub 2018 Jun 1.
442 Phylogenetic analysis of IDD gene family and characterization of its expression in response to flower induction in Malus.Mol Genet Genomics. 2017 Aug;292(4):755-771. doi: 10.1007/s00438-017-1306-4. Epub 2017 Mar 17.
443 The economic impact of insulin-related hypoglycemia in Denmark: an analysis using the Local Impact of Hypoglycemia Tool.J Med Econ. 2017 Apr;20(4):363-370. doi: 10.1080/13696998.2016.1269774. Epub 2016 Dec 21.
444 Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females.Hum Mol Genet. 2003 May 15;12(10):1101-10. doi: 10.1093/hmg/ddg132.
445 Association of single nucleotide polymorphisms in cytotoxic T-lymphocyte antigen 4 and susceptibility to autoimmune type 1 diabetes in Tunisians.Clin Vaccine Immunol. 2010 Sep;17(9):1473-7. doi: 10.1128/CVI.00099-10. Epub 2010 Jul 7.
446 Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy.Diabetes. 2009 Nov;58(11):2698-702. doi: 10.2337/db09-0641. Epub 2009 Aug 3.
447 Mig6 haploinsufficiency protects mice against streptozotocin-induced diabetes.Diabetologia. 2014 Oct;57(10):2066-75. doi: 10.1007/s00125-014-3311-z. Epub 2014 Jul 4.
448 Multivariate eQTL mapping uncovers functional variation on the X-chromosome associated with complex disease traits.Hum Genet. 2016 Jul;135(7):827-39. doi: 10.1007/s00439-016-1674-6. Epub 2016 May 7.
449 Follow-up of 1715 SNPs from the Wellcome Trust Case Control Consortium genome-wide association study in type I diabetes families.Genes Immun. 2009 Dec;10 Suppl 1(Suppl 1):S85-94. doi: 10.1038/gene.2009.97.
450 ATPase4A Autoreactivity and Its Association With Autoimmune Phenotypes in the Type 1 Diabetes Genetics Consortium Study.Diabetes Care. 2015 Oct;38 Suppl 2(Suppl 2):S29-36. doi: 10.2337/dcs15-2006.
451 Comprehensive evaluation of differential lncRNA and gene expression in patients with intervertebral disc degeneration.Mol Med Rep. 2018 Aug;18(2):1504-1512. doi: 10.3892/mmr.2018.9128. Epub 2018 Jun 5.
452 Short Communication FYB polymorphisms in Brazilian patients with type I diabetes mellitus and autoimmune polyglandular syndrome type III.Genet Mol Res. 2015 Jan 15;14(1):29-33. doi: 10.4238/2015.January.15.4.
453 Genetic variability of GCKR alters lipid profiles in children with monogenic and autoimmune diabetes.Exp Clin Endocrinol Diabetes. 2014 Oct;122(9):503-9. doi: 10.1055/s-0034-1375648. Epub 2014 Jun 11.
454 Role of increased ROS dissipation in prevention of T1D.Ann N Y Acad Sci. 2008 Dec;1150:157-66. doi: 10.1196/annals.1447.045.
455 GIMAP GTPase family genes: potential modifiers in autoimmune diabetes, asthma, and allergy.J Immunol. 2015 Jun 15;194(12):5885-94. doi: 10.4049/jimmunol.1500016. Epub 2015 May 11.
456 Emerging roles of GLIS3 in neonatal diabetes, type 1 and type 2 diabetes.J Mol Endocrinol. 2017 Feb;58(2):R73-R85. doi: 10.1530/JME-16-0232. Epub 2016 Nov 29.
457 A splice variant of GNB3 and peripheral polyneuropathy in type 1 diabetes.Dis Markers. 2009;26(3):111-7. doi: 10.3233/DMA-2009-0620.
458 GPT2 mutations cause developmental encephalopathy with microcephaly and features of complicated hereditary spastic paraplegia.Clin Genet. 2018 Oct;94(3-4):356-361. doi: 10.1111/cge.13390. Epub 2018 Jul 10.
459 Genetic association analyses of atopic illness and proinflammatory cytokine genes with type 1 diabetes.Diabetes Metab Res Rev. 2011 Nov;27(8):838-43. doi: 10.1002/dmrr.1259.
460 High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach.Diabetes. 2008 Sep;57(9):2519-26. doi: 10.2337/db07-1086. Epub 2008 Jun 16.
461 HLA-DQA1 and HLA-DQB1 Alleles, Conferring Susceptibility to Celiac Disease and Type 1 Diabetes, are More Expressed Than Non-Predisposing Alleles and are Coordinately Regulated.Cells. 2019 Jul 19;8(7):751. doi: 10.3390/cells8070751.
462 Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice.Endocrinology. 2017 Apr 1;158(4):903-919. doi: 10.1210/en.2016-1576.
463 A rapid method to study heat shock protein 70-2 gene polymorphism in insulin-dependent diabetes mellitus.Pancreas. 1996 Oct;13(3):268-72. doi: 10.1097/00006676-199610000-00009.
464 IGF2BP2 and IGF2 genetic effects in diabetes and diabetic nephropathy.J Diabetes Complications. 2012 Sep-Oct;26(5):393-8. doi: 10.1016/j.jdiacomp.2012.05.012. Epub 2012 Jul 4.
465 Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes.Front Immunol. 2017 Jan 10;7:679. doi: 10.3389/fimmu.2016.00679. eCollection 2016.
466 INPPL1 is associated with the metabolic syndrome in men with Type 1 diabetes, but not with diabetic nephropathy.Diabet Med. 2012 Dec;29(12):1589-95. doi: 10.1111/j.1464-5491.2012.03668.x.
467 Predominance of the group A killer Ig-like receptor haplotypes in Korean patients with T1D.Ann N Y Acad Sci. 2006 Oct;1079:240-50. doi: 10.1196/annals.1375.037.
468 Killer cell immunoglobulin-like receptor along with HLA-C ligand genes are associated with type 1 diabetes in Chinese Han population.Diabetes Metab Res Rev. 2011 Nov;27(8):872-7. doi: 10.1002/dmrr.1264.
469 Low gene expression levels of activating receptors of natural killer cells (NKG2E and CD94) in patients with fulminant type 1 diabetes.Immunol Lett. 2013 Nov-Dec;156(1-2):149-55. doi: 10.1016/j.imlet.2013.10.004. Epub 2013 Oct 25.
470 Defective activation of p21ras in peripheral blood mononuclear cells from patients with insulin dependent diabetes mellitus.Autoimmunity. 1999;29(2):147-54. doi: 10.3109/08916939908995385.
471 LRBA deficiency with autoimmunity and early onset chronic erosive polyarthritis.Clin Immunol. 2016 Jul;168:88-93. doi: 10.1016/j.clim.2016.03.006. Epub 2016 Apr 5.
472 Insulin transactivator MafA regulates intrathymic expression of insulin and affects susceptibility to type 1 diabetes.Diabetes. 2010 Oct;59(10):2579-87. doi: 10.2337/db10-0476. Epub 2010 Aug 3.
473 Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus.BMC Med Genet. 2010 Jul 28;11:116. doi: 10.1186/1471-2350-11-116.
474 Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition.Oncotarget. 2016 May 24;7(21):31053-66. doi: 10.18632/oncotarget.8842.
475 Very High Prevalence of Frozen Shoulder in Patients With Type 1 Diabetes of ?5 Years' Duration: The Dialong Shoulder Study.Arch Phys Med Rehabil. 2017 Aug;98(8):1551-1559. doi: 10.1016/j.apmr.2017.01.020. Epub 2017 Feb 17.
476 Association between microfibrillar-associated protein 4 (MFAP4) and micro- and macrovascular complications in long-term type 1 diabetes mellitus.Acta Diabetol. 2017 Apr;54(4):367-372. doi: 10.1007/s00592-016-0953-y. Epub 2016 Dec 30.
477 Incorporating parental information into family-based association tests.Biostatistics. 2013 Jul;14(3):556-72. doi: 10.1093/biostatistics/kxs048. Epub 2012 Dec 23.
478 Polymorphisms of myo-inositol oxygenase gene are associated with Type 1 diabetes mellitus.J Diabetes Complications. 2010 Nov-Dec;24(6):404-8. doi: 10.1016/j.jdiacomp.2009.09.005. Epub 2009 Nov 6.
479 Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression.Diabetes. 2012 Apr;61(4):954-62. doi: 10.2337/db11-1263. Epub 2012 Feb 16.
480 Association analysis of myosin IXB and type 1 diabetes.Hum Immunol. 2010 Jun;71(6):598-601. doi: 10.1016/j.humimm.2010.03.002. Epub 2010 Apr 1.
481 Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes.Ann N Y Acad Sci. 2006 Oct;1079:186-9. doi: 10.1196/annals.1375.029.
482 Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.PLoS One. 2016 May 13;11(5):e0155643. doi: 10.1371/journal.pone.0155643. eCollection 2016.
483 Roles of miR-494 in Intervertebral Disk Degeneration and the Related Mechanism.World Neurosurg. 2018 Dec 30:S1878-8750(18)32921-8. doi: 10.1016/j.wneu.2018.12.098. Online ahead of print.
484 Analysis of the intronic single nucleotide polymorphism rs#466452 of the nephrin gene in patients with diabetic nephropathy.Biol Res. 2009;42(2):189-98. Epub 2009 Aug 20.
485 Elevated N-acetyl--d-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study.J Diabetes Complications. 2018 Aug;32(8):777-783. doi: 10.1016/j.jdiacomp.2018.05.019. Epub 2018 Jun 1.
486 Haplotype specific alteration of diabetes MHC risk by olfactory receptor gene polymorphism.Autoimmun Rev. 2012 Dec;12(2):270-4. doi: 10.1016/j.autrev.2012.05.001. Epub 2012 May 8.
487 Pannexin-2-deficiency sensitizes pancreatic -cells to cytokine-induced apoptosis invitro and impairs glucose tolerance invivo.Mol Cell Endocrinol. 2017 Jun 15;448:108-121. doi: 10.1016/j.mce.2017.04.001. Epub 2017 Apr 5.
488 Persistent STAT5 phosphorylation and epigenetic dysregulation of GM-CSF and PGS2/COX2 expression in Type 1 diabetic human monocytes.PLoS One. 2013 Oct 18;8(10):e76919. doi: 10.1371/journal.pone.0076919. eCollection 2013.
489 Post-translational protein modifications in type 1 diabetes: a role for the repair enzyme protein-L-isoaspartate (D-aspartate) O-methyltransferase?.Diabetologia. 2007 Mar;50(3):676-81. doi: 10.1007/s00125-006-0556-1. Epub 2007 Jan 10.
490 Factors Affecting Self-Care Performance in Adolescents with Type I Diabetes According to the PEN-3 Cultural Model.Int J Endocrinol Metab. 2018 Sep 18;16(4):e62582. doi: 10.5812/ijem.62582. eCollection 2018 Oct.
491 CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity.Horm Metab Res. 2009 Jun;41(6):426-9. doi: 10.1055/s-0029-1214414.
492 The matrikine N-acetylated proline-glycine-proline induces premature senescence of nucleus pulposus cells via CXCR1-dependent ROS accumulation and DNA damage and reinforces the destructive effect of these cells on homeostasis of intervertebral discs.Biochim Biophys Acta Mol Basis Dis. 2017 Jan;1863(1):220-230. doi: 10.1016/j.bbadis.2016.10.011. Epub 2016 Oct 19.
493 Allelic variants in the PHTF1-PTPN22, C12orf30 and CD226 regions as candidate susceptibility factors for the type 1 diabetes in the Estonian population.BMC Med Genet. 2010 Jan 20;11:11. doi: 10.1186/1471-2350-11-11.
494 Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice.Hum Gene Ther. 2006 Jun;17(6):625-34. doi: 10.1089/hum.2006.17.625.
495 Innate Viral Receptor Signaling Determines Type 1 Diabetes Onset.Front Endocrinol (Lausanne). 2017 Sep 26;8:249. doi: 10.3389/fendo.2017.00249. eCollection 2017.
496 Predictors of changing insulin dose requirements and glycaemic control in children, adolescents and young adults with Type 1 diabetes.Diabet Med. 2018 Oct;35(10):1355-1363. doi: 10.1111/dme.13699. Epub 2018 Jun 19.
497 Genome-wide association analysis of imputed rare variants: application to seven common complex diseases.Genet Epidemiol. 2012 Dec;36(8):785-96. doi: 10.1002/gepi.21675. Epub 2012 Sep 5.
498 GATA factors promote ER integrity and -cell survival and contribute to type 1 diabetes risk.Mol Endocrinol. 2014 Jan;28(1):28-39. doi: 10.1210/me.2013-1265. Epub 2013 Jan 1.
499 Genetic Determinants of Enterovirus Infections: Polymorphisms in Type 1 Diabetes and Innate Immune Genes in the MIDIA Study.Viral Immunol. 2015 Dec;28(10):556-63. doi: 10.1089/vim.2015.0067. Epub 2015 Oct 20.
500 ig-h3 Represses T-Cell Activation in Type 1 Diabetes.Diabetes. 2015 Dec;64(12):4212-9. doi: 10.2337/db15-0638. Epub 2015 Oct 15.
501 RASSF7 expression and its regulatory roles on apoptosis in human intervertebral disc degeneration.Int J Clin Exp Pathol. 2015 Dec 1;8(12):16097-103. eCollection 2015.
502 Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.Nat Genet. 2007 Sep;39(9):1074-82. doi: 10.1038/ng2102. Epub 2007 Aug 5.
503 Vitamin D-resistant rickets and type 1 diabetes in a child with compound heterozygous mutations of the vitamin D receptor (L263R and R391S): dissociated responses of the CYP-24 and rel-B promoters to 1,25-dihydroxyvitamin D3.J Bone Miner Res. 2006 Jun;21(6):886-94. doi: 10.1359/jbmr.060307.
504 The autoimmunity-associated gene RGS1 affects the frequency of T follicular helper cells.Genes Immun. 2016 Jun;17(4):228-38. doi: 10.1038/gene.2016.16. Epub 2016 Mar 31.
505 Effect of Catha edulis (khat) on pancreatic functions in streptozotocin-induced diabetes in male Sprague-Dawley rats.Exp Anim. 2018 Nov 1;67(4):517-526. doi: 10.1538/expanim.18-0057. Epub 2018 Jul 3.
506 Recurrent nonsevere hypoglycemia exacerbates imbalance of mitochondrial homeostasis leading to synapse injury and cognitive deficit in diabetes.Am J Physiol Endocrinol Metab. 2018 Nov 1;315(5):E973-E986. doi: 10.1152/ajpendo.00133.2018. Epub 2018 Jul 3.
507 Role of DNA methylation at the placental RTL1 gene locus in type 1 diabetes.Pediatr Diabetes. 2017 May;18(3):178-187. doi: 10.1111/pedi.12387. Epub 2016 May 13.
508 Innate resistance to flavivirus infections and the functions of 2'-5' oligoadenylate synthetases.Curr Top Microbiol Immunol. 2008;321:85-100. doi: 10.1007/978-3-540-75203-5_4.
509 Conventional and Neo-antigenic Peptides Presented by Cells Are Targeted by Circulating Nave CD8+ T Cells in Type 1 Diabetic and Healthy Donors.Cell Metab. 2018 Dec 4;28(6):946-960.e6. doi: 10.1016/j.cmet.2018.07.007. Epub 2018 Aug 2.
510 Polymorphisms in the selenoprotein S gene: lack of association with autoimmune inflammatory diseases.BMC Genomics. 2008 Jul 14;9:329. doi: 10.1186/1471-2164-9-329.
511 Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?.J Med Genet. 2006 Feb;43(2):129-32. doi: 10.1136/jmg.2005.035212. Epub 2005 Jul 13.
512 Association study of polymorphisms in SOCS family genes with type 1 diabetes mellitus.Int J Immunogenet. 2006 Feb;33(1):7-10. doi: 10.1111/j.1744-313X.2006.00563.x.
513 A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.Science. 2000 Apr 21;288(5465):505-11. doi: 10.1126/science.288.5465.505.
514 Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease.J Am Heart Assoc. 2017 Apr 1;6(4):e005146. doi: 10.1161/JAHA.116.005146.
515 Drak2 is not required for tumor surveillance and suppression.Int Immunol. 2015 Mar;27(3):161-6. doi: 10.1093/intimm/dxu146. Epub 2015 Jan 7.
516 Microarray based analysis of gene regulation by microRNA in intervertebral disc degeneration.Mol Med Rep. 2015 Oct;12(4):4925-30. doi: 10.3892/mmr.2015.4022. Epub 2015 Jul 2.
517 Shared and distinct genetic variants in type 1 diabetes and celiac disease.N Engl J Med. 2008 Dec 25;359(26):2767-77. doi: 10.1056/NEJMoa0807917. Epub 2008 Dec 10.
518 Genetic and functional data identifying Cd101 as a type 1 diabetes (T1D) susceptibility gene in nonobese diabetic (NOD) mice.PLoS Genet. 2019 Jun 14;15(6):e1008178. doi: 10.1371/journal.pgen.1008178. eCollection 2019 Jun.
519 Fecal pancreatic elastase-1 and erythrocyte magnesium levels in diabetes type 1 and type 2.Magnes Res. 2018 Feb 1;31(1):1-10. doi: 10.1684/mrh.2018.0433.
520 Antibodies to post-translationally modified mitochondrial peptide PDC-E2(167-184) in type 1 diabetes.Arch Biochem Biophys. 2018 Dec 1;659:66-74. doi: 10.1016/j.abb.2018.09.021. Epub 2018 Sep 25.
521 miR15a and miR16 in Chilean type 1 diabetes patients: possible association with apoptosis, inflammatory, or autoimmunity markers.J Endocrinol Invest. 2018 Jan 31. doi: 10.1007/s40618-017-0814-8. Online ahead of print.
522 Urine inositol pentakisphosphate 2-kinase and changes in kidney structure in early diabetic kidney disease in type 1 diabetes.Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1484-F1492. doi: 10.1152/ajprenal.00183.2018. Epub 2018 Aug 22.
523 Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls.J Pediatr Endocrinol Metab. 2018 Sep 25;31(9):959-969. doi: 10.1515/jpem-2018-0353.
524 Sodium-glucose co-transporter inhibitors, their role in type 1 diabetes treatment and a risk mitigation strategy for preventing diabetic ketoacidosis: The STOP DKA Protocol.Diabetes Obes Metab. 2019 Oct;21(10):2192-2202. doi: 10.1111/dom.13811. Epub 2019 Jun 30.
525 Exosomes from mesenchymal stem cells modulate endoplasmic reticulum stress to protect against nucleus pulposus cell death and ameliorate intervertebral disc degeneration in vivo.Theranostics. 2019 May 31;9(14):4084-4100. doi: 10.7150/thno.33638. eCollection 2019.
526 A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes.Sci Transl Med. 2018 Jan 3;10(422):eaag1782. doi: 10.1126/scitranslmed.aag1782.
527 Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction.Sci Rep. 2019 Nov 6;9(1):16103. doi: 10.1038/s41598-019-52331-1.
528 Neurologic disorders associated with anti-glutamic acid decarboxylase antibodies: A comparison of anti-GAD antibody titers and time-dependent changes between neurologic disease and type I diabetes mellitus.J Neuroimmunol. 2018 Apr 15;317:84-89. doi: 10.1016/j.jneuroim.2018.01.007. Epub 2018 Jan 9.
529 RNASEH1 gene variants are associated with autoimmune type 1 diabetes in Colombia.J Endocrinol Invest. 2018 Jul;41(7):755-764. doi: 10.1007/s40618-017-0797-5. Epub 2017 Dec 4.
530 Decreased Spexin Levels in Patients with Type 1 and Type 2 Diabetes.Med Princ Pract. 2018;27(6):549-554. doi: 10.1159/000493482. Epub 2018 Sep 5.
531 TSG-6 secreted by bone marrow mesenchymal stem cells attenuates intervertebral disc degeneration by inhibiting the TLR2/NF-B signaling pathway.Lab Invest. 2018 Jun;98(6):755-772. doi: 10.1038/s41374-018-0036-5. Epub 2018 Feb 26.
532 Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1.Dis Markers. 1990 Sep-Oct;8(5):283-94.
533 Activated platelets in subjects at increased risk of IDDM. DENIS Study Group. Deutsche Nikotinamid Interventionsstudie.Diabetologia. 1997 May;40(5):573-7. doi: 10.1007/s001250050717.
534 Nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) P22 Phox C242T gene polymorphism in type 1 diabetes.Ann N Y Acad Sci. 2003 Nov;1005:324-7. doi: 10.1196/annals.1288.051.
535 Association of diabetic neuropathy with Na/K ATPase gene polymorphism.Diabetologia. 1997 May;40(5):506-11. doi: 10.1007/s001250050708.
536 HLA, ESD, GLOI, C3 and HP polymorphisms and juvenile insulin dependent diabetes mellitus in Tamil Nadu (south India).Diabetes Res Clin Pract. 1994 Aug;25(1):51-9. doi: 10.1016/0168-8227(94)90161-9.
537 Fine-mapping of the type 1 diabetes locus (IDDM4) on chromosome 11q and evaluation of two candidate genes (FADD and GALN) by affected sibpair and linkage-disequilibrium analyses.Hum Genet. 2000 Jan;106(1):14-8. doi: 10.1007/s004399900186.
538 Type 1 diabetic mellitus patients with increased atherosclerosis risk display decreased CDKN2A/2B/2BAS gene expression in leukocytes.J Transl Med. 2019 Jul 12;17(1):222. doi: 10.1186/s12967-019-1977-1.
539 Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes: studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort.Diabetes Care. 2003 May;26(5):1439-48. doi: 10.2337/diacare.26.5.1439.
540 Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q.Nature. 1994 Sep 8;371(6493):161-4. doi: 10.1038/371161a0.
541 IDDM7 links to insulin-dependent diabetes mellitus in Danish multiplex families but linkage is not explained by novel polymorphisms in the candidate gene GALNT3. The Danish Study Group of Diabetes in Childhood and The Danish IDDM Epidemiology and Genetics Group.Hum Mutat. 2000 Mar;15(3):295-6. doi: 10.1002/(SICI)1098-1004(200003)15:3<295::AID-HUMU16>3.0.CO;2-5.
542 Lymphopenia in the BB rat model of type 1 diabetes is due to a mutation in a novel immune-associated nucleotide (Ian)-related gene.Genome Res. 2002 Jul;12(7):1029-39. doi: 10.1101/gr.412702.
543 A missense mutation of the muscle glycogen synthase gene (M416V) is associated with insulin resistance in the Japanese population.Diabetologia. 1997 Aug;40(8):947-52. doi: 10.1007/s001250050772.
544 The HLA-E locus is associated with age at onset and susceptibility to type 1 diabetes mellitus.Hum Immunol. 2000 Mar;61(3):290-5. doi: 10.1016/s0198-8859(99)00116-0.
545 The HOXD8 locus (2q31) is linked to type I diabetes. Interaction with chromosome 6 and 11 disease susceptibility genes.Diabetes. 1995 Jan;44(1):132-6. doi: 10.2337/diab.44.1.132.
546 Influence of allele lineage on the role of the insulin minisatellite in susceptibility to type 1 diabetes.Hum Mol Genet. 2000 Dec 12;9(20):2929-35. doi: 10.1093/hmg/9.20.2929.
547 Definition of polymorphisms in the gene encoding the interleukin-12 receptor B1 subunit: testing linkage disequilibrium with Type I diabetes susceptibility.Genes Immun. 2003 Apr;4(3):222-7. doi: 10.1038/sj.gene.6363948.
548 A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes.Diabetes. 2002 Apr;51(4):1208-13. doi: 10.2337/diabetes.51.4.1208.
549 Antibodies to glutamic acid decarboxylase are associated with HLA-DR genotypes in both Australians and Asians with type 1 (insulin-dependent) diabetes mellitus.Diabetologia. 1992 Oct;35(10):996-1001. doi: 10.1007/BF00401432.
550 Characterisation of glucose transporters in the intact coronary artery endothelium in rats: GLUT-2 upregulated by long-term hyperglycaemia.Diabetologia. 2004 Dec;47(12):2081-92. doi: 10.1007/s00125-004-1583-4. Epub 2004 Dec 10.
551 Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significance.Scand J Immunol. 1987 Mar;25(3):235-43. doi: 10.1111/j.1365-3083.1987.tb01069.x.
552 Monokine antagonism is reduced in patients with IDDM.Diabetes. 1994 Oct;43(10):1242-7. doi: 10.2337/diab.43.10.1242.
553 IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese.Tissue Antigens. 2004 Mar;63(3):223-30. doi: 10.1111/j.0001-2815.2004.00164.x.
554 Association study of human MTH1 gene polymorphisms with type 1 diabetes mellitus.Endocr J. 2004 Oct;51(5):493-8. doi: 10.1507/endocrj.51.493.
555 The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.Kidney Int. 2004 Feb;65(2):540-50. doi: 10.1111/j.1523-1755.2004.00407.x.
556 Autoimmunogenic HLA-DRB1*0301 allele (DR3) may be distinguished at the DRB1 non-coding regions of HLA-B8,DR3,Dw24 and B18,DR3,Dw25 haplotypes.Mol Immunol. 1991 Jan-Feb;28(1-2):189-92. doi: 10.1016/0161-5890(91)90105-s.
557 Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA Class I expression in type I diabetic cells.Hum Gene Ther. 1995 Aug;6(8):1005-17. doi: 10.1089/hum.1995.6.8-1005.
558 Adaptation and validation of the German Patient Activation Measure for adolescents with chronic conditions in transitional care: PAM() 13 for Adolescents.Res Nurs Health. 2018 Feb;41(1):78-87. doi: 10.1002/nur.21831. Epub 2017 Dec 20.
559 The Role of Type I Diabetes in Intervertebral Disc Degeneration.Spine (Phila Pa 1976). 2019 Sep 1;44(17):1177-1185. doi: 10.1097/BRS.0000000000003054.
560 A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.Arterioscler Thromb Vasc Biol. 2017 Jun;37(6):1194-1205. doi: 10.1161/ATVBAHA.117.309275. Epub 2017 Apr 6.
561 Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements.Nutr Metab (Lond). 2018 May 3;15:33. doi: 10.1186/s12986-018-0271-1. eCollection 2018.
562 A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both A1C and glucose.Diabetes. 2010 Feb;59(2):539-49. doi: 10.2337/db09-0653. Epub 2009 Oct 29.
563 BTNL2-Ig Protein Attenuates Type 1 Diabetes in Non-Obese Diabetic (NOD) Mice.Adv Healthc Mater. 2019 May;8(9):e1800987. doi: 10.1002/adhm.201800987. Epub 2019 Mar 18.
564 C4 Chido 3 and 6 distinguish two diabetogenic haplotypes: HLA-B49, SC01,DR4,DQw8 and B8,SC01,DR3,DQw2.Immunobiology. 1991 Sep;183(1-2):12-22. doi: 10.1016/S0171-2985(11)80182-8.
565 Association of rs 3807337 polymorphism of CALD1 gene with diabetic nephropathy occurrence in type 1 diabetes - preliminary results of a family-based study.Endokrynol Pol. 2017;68(1):13-17. doi: 10.5603/EP.2017.0003.
566 Levels of cytokines and GADA in type I and II diabetic patients.Prim Care Diabetes. 2020 Feb;14(1):61-67. doi: 10.1016/j.pcd.2019.03.008. Epub 2019 Apr 20.
567 Chromogranin A and its role in the pathogenesis of diabetes mellitus.Endokrynol Pol. 2018;69(5):598-610. doi: 10.5603/EP.a2018.0052. Epub 2018 Aug 3.
568 Variability in the CIITA gene interacts with HLA in multiple sclerosis.Genes Immun. 2014 Apr-May;15(3):162-7. doi: 10.1038/gene.2013.71. Epub 2014 Jan 16.
569 The type 1 diabetes candidate gene Dexi does not affect disease risk in the nonobese diabetic mouse model.Genes Immun. 2020 Jan;21(1):71-77. doi: 10.1038/s41435-019-0083-y. Epub 2019 Aug 22.
570 Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.Nature. 2007 Jun 7;447(7145):661-78. doi: 10.1038/nature05911.
571 Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction.PLoS One. 2015 May 14;10(5):e0126866. doi: 10.1371/journal.pone.0126866. eCollection 2015.
572 Serum copper profile in patients with type 1 diabetes in comparison to other metals.J Trace Elem Med Biol. 2019 Dec;56:156-161. doi: 10.1016/j.jtemb.2019.08.011. Epub 2019 Aug 23.
573 Dietary Cows' Milk Protein A1 Beta-Casein Increases the Incidence of T1D in NOD Mice.Nutrients. 2018 Sep 12;10(9):1291. doi: 10.3390/nu10091291.
574 1000 Genomes-based imputation identifies novel and refined associations for the Wellcome Trust Case Control Consortium phase 1 Data.Eur J Hum Genet. 2012 Jul;20(7):801-5. doi: 10.1038/ejhg.2012.3. Epub 2012 Feb 1.
575 Association of Polymorphisms in CYBA, SOD1, and CAT Genes with Type 1 Diabetes and Diabetic Peripheral Neuropathy in Children and Adolescents.Genet Test Mol Biomarkers. 2018 Jul;22(7):413-419. doi: 10.1089/gtmb.2018.0018. Epub 2018 Jun 20.
576 The Role of Vitamin D Binding Protein, Total and Free 25-Hydroxyvitamin D in Diabetes.Front Endocrinol (Lausanne). 2019 Feb 19;10:79. doi: 10.3389/fendo.2019.00079. eCollection 2019.
577 A novel Dock8 gene mutation confers diabetogenic susceptibility in the LEW.1AR1/Ztm-iddm rat, an animal model of human type 1 diabetes.Diabetologia. 2015 Dec;58(12):2800-9. doi: 10.1007/s00125-015-3757-7. Epub 2015 Sep 12.
578 Coincidence of PTPN22 c.1858CC and FCRL3 -169CC genotypes as a biomarker of preserved residual -cell function in children with type 1 diabetes.Pediatr Diabetes. 2017 Dec;18(8):696-705. doi: 10.1111/pedi.12429. Epub 2016 Sep 12.
579 Molecular Pathways for Immune Recognition of Preproinsulin Signal Peptide in Type 1 Diabetes.Diabetes. 2018 Apr;67(4):687-696. doi: 10.2337/db17-0021. Epub 2018 Jan 17.
580 Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.Diabetologia. 2018 Apr;61(4):977-984. doi: 10.1007/s00125-017-4510-1. Epub 2017 Nov 28.
581 Confirmation of GLRA3 as a susceptibility locus for albuminuria in Finnish patients with type 1 diabetes.Sci Rep. 2018 Aug 17;8(1):12408. doi: 10.1038/s41598-018-29211-1.
582 Variants associated with autoimmune Type 1 diabetes in Japanese children: implications for age-specific effects of cis-regulatory haplotypes at 17q12-q21.Diabet Med. 2016 Dec;33(12):1717-1722. doi: 10.1111/dme.13175. Epub 2016 Jul 15.
583 Protective effects of curcumin on diabetic nephropathy via attenuation of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) expression and alleviation of oxidative stress in rats with type 1 diabetes.Iran J Basic Med Sci. 2019 Apr;22(4):376-383. doi: 10.22038/ijbms.2019.31922.7674.
584 Cell-based immunomodulatory therapy approaches for type 1 diabetes mellitus.Drug Discov Today. 2020 Feb;25(2):380-391. doi: 10.1016/j.drudis.2019.11.016. Epub 2019 Dec 12.
585 HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families.Diabetes. 2010 Aug;59(8):2055-62. doi: 10.2337/db09-0680. Epub 2010 Apr 27.
586 Genetic Variation Within the HLA-DRA1 Gene Modulates Susceptibility to Type 1 Diabetes in HLA-DR3 Homozygotes.Diabetes. 2019 Jul;68(7):1523-1527. doi: 10.2337/db18-1128. Epub 2019 Apr 8.
587 Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4, and 5 Include Potentially Causal Residues Responsible for the Risk of Childhood Type 1 Diabetes.Diabetes. 2019 Aug;68(8):1692-1704. doi: 10.2337/db19-0273. Epub 2019 May 24.
588 HLA-A3, B7 linkage disequilibrium in hemochromatotic patients with or without insulin dependent diabetes.Tissue Antigens. 1981 May;17(5):473-9. doi: 10.1111/j.1399-0039.1981.tb00733.x.
589 T cells and autoantibodies to human HSP70 in type 1 diabetes in children.J Autoimmun. 2003 Jun;20(4):313-21. doi: 10.1016/s0896-8411(03)00038-6.
590 KEGG-expressed genes and pathways in intervertebral disc degeneration: Protocol for a systematic review and data mining.Medicine (Baltimore). 2019 May;98(21):e15796. doi: 10.1097/MD.0000000000015796.
591 Epigenetic modulation of cells by interferon- via PNPT1/mir-26a/TET2 triggers autoimmune diabetes.JCI Insight. 2019 Mar 7;4(5):e126663. doi: 10.1172/jci.insight.126663. eCollection 2019 Mar 7.
592 Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.Pediatr Diabetes. 2013 Nov;14(7):490-6. doi: 10.1111/pedi.12046. Epub 2013 May 31.
593 Autoantibodies against islet cell antigens in children with type 1 diabetes mellitus.Oncotarget. 2018 Feb 19;9(23):16275-16283. doi: 10.18632/oncotarget.24527. eCollection 2018 Mar 27.
594 Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants.PLoS Genet. 2012;8(6):e1002707. doi: 10.1371/journal.pgen.1002707. Epub 2012 Jun 7.
595 RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles.Physiol Genomics. 2013 Apr 1;45(7):287-99. doi: 10.1152/physiolgenomics.00001.2013. Epub 2013 Feb 5.
596 The KL-VS polymorphism of KLOTHO gene is protective against retinopathy incidence in patients with type 1 diabetes.Biochim Biophys Acta Mol Basis Dis. 2018 Mar;1864(3):758-763. doi: 10.1016/j.bbadis.2017.12.015. Epub 2017 Dec 13.
597 Autoimmunity-Associated PTPN22 Polymorphisms in Latent Autoimmune Diabetes of the Adult Differ from Those of Type 1 Diabetes Patients.Int Arch Allergy Immunol. 2018;177(1):57-68. doi: 10.1159/000489225. Epub 2018 Jun 12.
598 Interactions between maternal killer cell immunoglobulin receptor genes and foetal HLA ligand genes contribute to type 1 diabetes susceptibility in Han Chinese.Int J Immunogenet. 2016 Jun;43(3):125-30. doi: 10.1111/iji.12257. Epub 2016 Mar 17.
599 Several loci in the HLA class III region are associated with T1D risk after adjusting for DRB1-DQB1.Diabetes Obes Metab. 2009 Feb;11 Suppl 1(Suppl 1):46-52. doi: 10.1111/j.1463-1326.2008.01002.x.
600 Null mutations of NEUROG3 are associated with delayed-onset diabetes mellitus.JCI Insight. 2020 Jan 16;5(1):e127657. doi: 10.1172/jci.insight.127657.
601 A retrospective observational study of people with Type 1 diabetes with self-reported severe hypoglycaemia reveals high level of ambulance attendance but low levels of therapy change and specialist intervention.Diabet Med. 2018 May 15. doi: 10.1111/dme.13670. Online ahead of print.
602 Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders.Am J Med Genet B Neuropsychiatr Genet. 2012 Apr;159B(3):354-8. doi: 10.1002/ajmg.b.32036. Epub 2012 Feb 15.
603 Reassessment of the type I diabetes association of the OAS1 locus.Genes Immun. 2009 Dec;10 Suppl 1(Suppl 1):S69-73. doi: 10.1038/gene.2009.95.
604 Susceptibility to type 1 diabetes in the Senegalese population is linked to HLA-DQ and not TAP and LMP genes.Diabetes Care. 1997 Aug;20(8):1299-303. doi: 10.2337/diacare.20.8.1299.
605 Optical coherence tomography angiography study of the retinal vascular plexuses in type 1 diabetes without retinopathy.Eye (Lond). 2020 Feb;34(2):307-311. doi: 10.1038/s41433-019-0513-0. Epub 2019 Jul 4.
606 Variations of the perforin gene in patients with type 1 diabetes.Diabetes. 2008 Apr;57(4):1078-83. doi: 10.2337/db07-0947. Epub 2008 Jan 15.
607 Long non-coding RNAs in nucleus pulposus cell function and intervertebral disc degeneration.Cell Prolif. 2018 Oct;51(5):e12483. doi: 10.1111/cpr.12483. Epub 2018 Jul 24.
608 Early Glomerular Hyperfiltration and Long-Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience.Clin J Am Soc Nephrol. 2019 Jun 7;14(6):854-861. doi: 10.2215/CJN.14831218. Epub 2019 May 23.
609 Circulating Reg1 proteins and autoantibodies to Reg1 proteins as biomarkers of -cell regeneration and damage in type 1 diabetes.Horm Metab Res. 2010 Dec;42(13):955-60. doi: 10.1055/s-0030-1267206. Epub 2010 Oct 22.
610 PD-1 gene haplotype is associated with the development of type 1 diabetes mellitus in Japanese children.Hum Genet. 2007 Apr;121(2):223-32. doi: 10.1007/s00439-006-0309-8. Epub 2007 Jan 3.
611 Blood pressure, antihypertensive medication use, and risk of erectile dysfunction in men with type I diabetes.J Hypertens. 2019 May;37(5):1070-1076. doi: 10.1097/HJH.0000000000001988.
612 Autoimmunity-associated intronic SNP (rs2281808) detected by a simple phenotypic assay: Unique case or broader opportunity?.Clin Immunol. 2019 Jan;198:57-61. doi: 10.1016/j.clim.2018.12.018. Epub 2018 Dec 21.
613 SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes.Diabetologia. 2015 Mar;58(3):543-8. doi: 10.1007/s00125-014-3459-6. Epub 2014 Dec 6.
614 CREM variant rs17583959 conferred susceptibility to T1D risk in the Tunisian families.Immunol Lett. 2017 Jan;181:1-5. doi: 10.1016/j.imlet.2016.11.007. Epub 2016 Nov 10.
615 Transcriptional Regulation of Nos2 via STAT5B Binding to Nos2 Gene Promoter Mediates Nitric Oxide Production: Relevance in -Cell Maintenance.Cell Physiol Biochem. 2019;52(1):141-155. doi: 10.33594/000000010. Epub 2019 Feb 18.
616 Functional variants in SUMO4, TAB2, and NFkappaB and the risk of type 1 diabetes.Genes Immun. 2005 May;6(3):231-5. doi: 10.1038/sj.gene.6364174.
617 Effects of Orchidectomy and Testosterone Replacement on Numbers of Kisspeptin-, Neurokinin B-, and Dynorphin A-Immunoreactive Neurones in the Arcuate Nucleus of the Hypothalamus in Obese and Diabetic Rats.J Neuroendocrinol. 2017 Feb;29(2). doi: 10.1111/jne.12453.
618 No evidence for association of the TATA-box binding protein glutamine repeat sequence or the flanking chromosome 6q27 region with type 1 diabetes.Biochem Biophys Res Commun. 2005 Jun 3;331(2):435-41. doi: 10.1016/j.bbrc.2005.03.203.
619 TCF19 Promotes Cell Proliferation through Binding to the Histone H3K4me3 Mark.Biochemistry. 2020 Feb 4;59(4):389-399. doi: 10.1021/acs.biochem.9b00771. Epub 2019 Dec 2.
620 The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.Genes Immun. 2009 Dec;10 Suppl 1(Suppl 1):S121-7. doi: 10.1038/gene.2009.99.
621 Thyroid autoimmunity in relation to islet autoantibodies and HLA-DQ genotype in newly diagnosed type 1 diabetes in children and adolescents.Diabetologia. 2013 Aug;56(8):1735-42. doi: 10.1007/s00125-013-2934-9. Epub 2013 May 12.
622 Identification of diabetes- and obesity-associated proteomic changes in human spermatozoa by difference gel electrophoresis.Reprod Biomed Online. 2009 Nov;19(5):660-70. doi: 10.1016/j.rbmo.2009.07.001.
623 Transplantation of stem cells from umbilical cord blood as therapy for type I diabetes.Cell Tissue Res. 2019 Nov;378(2):155-162. doi: 10.1007/s00441-019-03046-2. Epub 2019 Jun 17.
624 Associations between genetic risk variants for kidney diseases and kidney disease etiology.Sci Rep. 2017 Oct 24;7(1):13944. doi: 10.1038/s41598-017-13356-6.
625 IL10 resistant PGS2 expression in at-risk/Type 1 diabetic human monocytes.J Autoimmun. 2004 May;22(3):227-33. doi: 10.1016/j.jaut.2003.12.006.
626 Impairment of amyloid precursor protein alpha-processing in cerebral microvessels of type 1 diabetic mice.J Cereb Blood Flow Metab. 2019 Jun;39(6):1085-1098. doi: 10.1177/0271678X17746981. Epub 2017 Dec 18.
627 Coeliac disease.Paediatr Int Child Health. 2019 Feb;39(1):23-31. doi: 10.1080/20469047.2018.1504431. Epub 2018 Aug 13.
628 SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.Endocr Pract. 2018 Jan;24(1):47-52. doi: 10.4158/EP-2017-0032. Epub 2017 Nov 16.
629 Angiopoietin-like protein 8 expression and association with extracellular matrix metabolism and inflammation during intervertebral disc degeneration.J Cell Mol Med. 2019 Aug;23(8):5737-5750. doi: 10.1111/jcmm.14488. Epub 2019 Jun 18.
630 Comparative analysis of gene expression profiles in children with type 1 diabetes mellitus.Mol Med Rep. 2019 May;19(5):3989-4000. doi: 10.3892/mmr.2019.10099. Epub 2019 Mar 28.
631 Abnormal islet sphingolipid metabolism in type 1 diabetes.Diabetologia. 2018 Jul;61(7):1650-1661. doi: 10.1007/s00125-018-4614-2. Epub 2018 Apr 18.
632 Inflammation-dependent downregulation of miR-194-5p contributes to human intervertebral disc degeneration by targeting CUL4A and CUL4B.J Cell Physiol. 2019 Nov;234(11):19977-19989. doi: 10.1002/jcp.28595. Epub 2019 Apr 3.
633 Cartilage intermediate layer protein is regulated by mechanical stress and affects extracellular matrix synthesis.Mol Med Rep. 2018 Apr;17(4):6130-6137. doi: 10.3892/mmr.2018.8588. Epub 2018 Feb 12.
634 Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetes.Diabetes. 2015 Feb;64(2):604-17. doi: 10.2337/db14-0803. Epub 2014 Sep 3.
635 Autoimmune endocrine diseases.Minerva Endocrinol. 2018 Sep;43(3):305-322. doi: 10.23736/S0391-1977.17.02757-2. Epub 2017 Oct 9.
636 A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study.Clin Exp Immunol. 2018 Jun;192(3):251-258. doi: 10.1111/cei.13115. Epub 2018 Mar 24.
637 Exocytosis Protein DOC2B as a Biomarker of Type 1 Diabetes.J Clin Endocrinol Metab. 2018 May 1;103(5):1966-1976. doi: 10.1210/jc.2017-02492.
638 Dipeptidyl peptidase-4 inhibitors (DPP-4i) combined with vitamin D3: An exploration to treat new-onset type 1 diabetes mellitus and latent autoimmune diabetes in adults in the future.Int Immunopharmacol. 2018 Apr;57:11-17. doi: 10.1016/j.intimp.2018.02.003. Epub 2018 Feb 22.
639 Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.Diabetes Obes Metab. 2019 Apr;21(4):1054-1057. doi: 10.1111/dom.13609. Epub 2019 Jan 8.
640 Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis.Diabetes Care. 2019 Feb;42(2):200-207. doi: 10.2337/dc18-1785.
641 Circular RNA GRB10 as a competitive endogenous RNA regulating nucleus pulposus cells death in degenerative intervertebral disk.Cell Death Dis. 2018 Feb 23;9(3):319. doi: 10.1038/s41419-017-0232-z.
642 Th17 pathway in recent-onset autoimmune diabetes.Cell Immunol. 2018 Feb;324:8-13. doi: 10.1016/j.cellimm.2017.11.005. Epub 2017 Nov 15.
643 LEAP2 changes with body mass and food intake in humans and mice.J Clin Invest. 2019 Sep 3;129(9):3909-3923. doi: 10.1172/JCI125332.
644 Type 1 diabetes upregulates metastasis-associated protein 1- phosphorylated histone 2AX signaling in the testis.Eur J Pharmacol. 2019 Mar 5;846:30-37. doi: 10.1016/j.ejphar.2019.01.019. Epub 2019 Jan 16.
645 Transport of Ca(2+) and Ca(2+)-Dependent Permeability Transition in Rat Liver Mitochondria under the Streptozotocin-Induced Type I Diabetes.Cells. 2019 Aug 30;8(9):1014. doi: 10.3390/cells8091014.
646 Assessment of Serum Concentrations of Adropin, Afamin, and Neudesin in Children with Type 1 Diabetes.Biomed Res Int. 2019 Oct 24;2019:6128410. doi: 10.1155/2019/6128410. eCollection 2019.
647 Neuropeptide B and neuropeptide W as new serum predictors of nutritional status and of clinical outcomes in pediatric patients with type 1 diabetes mellitus treated with the use of pens or insulin pumps.Arch Med Sci. 2019 May;15(3):619-631. doi: 10.5114/aoms.2018.75818. Epub 2018 May 16.
648 HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III.J Clin Endocrinol Metab. 2014 Jan;99(1):E177-82. doi: 10.1210/jc.2013-2852. Epub 2013 Dec 20.
649 CXCL4L1 Promoter Polymorphisms Are Associated with Improved Renal Function in Type 1 Diabetes.J Immunol. 2019 Feb 1;202(3):912-919. doi: 10.4049/jimmunol.1801086. Epub 2018 Dec 28.
650 Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes.Eur J Immunol. 2019 Aug;49(8):1235-1250. doi: 10.1002/eji.201948094. Epub 2019 Jun 5.
651 Upregulation of the long noncoding RNA lncPolE contributes to intervertebral disc degeneration by negatively regulating DNA polymerase epsilon.Am J Transl Res. 2019 May 15;11(5):2843-2854. eCollection 2019.
652 Effects of a Ganoderma atrum polysaccharide against pancreatic damage in streptozotocin-induced diabetic mice.Food Funct. 2019 Nov 1;10(11):7227-7238. doi: 10.1039/c9fo01990a. Epub 2019 Oct 16.
653 Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial.Diabetes Technol Ther. 2020 Sep;22(9):666-673. doi: 10.1089/dia.2019.0446. Epub 2020 Jan 28.
654 Prefronto-temporal white matter microstructural alterations 20years after the diagnosis of type 1 diabetes mellitus.Pediatr Diabetes. 2018 May;19(3):478-485. doi: 10.1111/pedi.12574. Epub 2017 Sep 20.
655 ICA12 autoantibodies are associated with non-DR3/non-DR4 in patients with latent autoimmune diabetes in adults from northern India.Ann N Y Acad Sci. 2002 Apr;958:329-32. doi: 10.1111/j.1749-6632.2002.tb02998.x.
656 Type 1 diabetes affects zona pellucida and genome methylation in oocytes and granulosa cells.Mol Cell Endocrinol. 2020 Jan 15;500:110627. doi: 10.1016/j.mce.2019.110627. Epub 2019 Oct 19.
657 The dietary education trial in carbohydrate counting (DIET-CARB Study): study protocol for a randomised, parallel, open-label, intervention study comparing different approaches to dietary self-management in patients with type 1 diabetes.BMJ Open. 2019 Sep 3;9(9):e029859. doi: 10.1136/bmjopen-2019-029859.
658 Silencing SUMO2 promotes protection against degradation and apoptosis of nucleus pulposus cells through p53 signaling pathway in intervertebral disc degeneration.Biosci Rep. 2018 Jun 29;38(3):BSR20171523. doi: 10.1042/BSR20171523. Print 2018 Jun 29.
659 Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.Mol Ther. 2018 Jan 3;26(1):184-198. doi: 10.1016/j.ymthe.2017.08.014. Epub 2017 Sep 7.
660 Association analysis between thrombospondin-2 gene polymorphisms and intervertebral disc degeneration in a Chinese Han population.Medicine (Baltimore). 2018 Jan;97(2):e9586. doi: 10.1097/MD.0000000000009586.
661 Urine Levels of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Children with Type 1 Diabetes Mellitus.J Clin Res Pediatr Endocrinol. 2019 May 28;11(2):157-163. doi: 10.4274/jcrpe.galenos.2018.2018.0221. Epub 2018 Nov 6.
662 Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model.PLoS One. 2019 Oct 24;14(10):e0217728. doi: 10.1371/journal.pone.0217728. eCollection 2019.